Oyh的个人主页 - 老虎社区

Oyh

Oyh

暂无个人介绍

IP属地：未知

199关注

13粉丝

0主题

0勋章

2021-08-22

Ok

抱歉，原内容已删除

2021-11-13

Ok

Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.

2021-10-30

Ok

Wall Street Crime and Punishment: Christian Meissenn And His Penny Stock Pump-And-Dump Games

2021-10-18

Ok

Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week

2021-08-09

👍🏼👍🏼👍🏼

抱歉，原内容已删除

2021-08-04

👍🏼👍🏼👍🏼

抱歉，原内容已删除

2021-11-06

Ok

抱歉，原内容已删除

2021-08-06

👍🏼👍🏼👍🏼

Nasdaq, S&P 500, set records as jobless claims decline

2021-08-01

🤔🤔🤔

Wall Street declines with Amazon; S&P 500 posts gains for month

2021-09-01

Ok

抱歉，原内容已删除

2021-12-18

Ok

Wall Street ends down after mostly negative week

2021-11-28

Ok

Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022

2021-11-16

Ok

Grab's ride-hailing services disrupted in Southeast Asian countries

2021-11-11

Ok

抱歉，原内容已删除

2021-11-05

Ok

Pfizer Develops Covid Pill That Cuts Hospitalizations and Deaths by 89%

2021-11-04

Ok

Arhaus Prices IPO At $13/Share, Below Expected Range

2021-10-30

Ok

Entrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share

2021-10-28

Ok

抱歉，原内容已删除

2021-10-26

Ok

Ocugen soared nearly 30% in premarket trading because of WHO’s meeting on its partner’s COVID-19 shot

2021-10-03

Ok

2 Ridiculously Cheap Growth Stocks to Buy

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3561459567222461","uuid":"3561459567222461","gmtCreate":1598365544339,"gmtModify":1624860469836,"name":"Oyh","pinyin":"oyh","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":13,"headSize":199,"tweetSize":125,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.47%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.84%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":693222962,"gmtCreate":1640043172229,"gmtModify":1640043240997,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693222962","repostId":"1154367089","repostType":4,"isVote":1,"tweetType":1,"viewCount":1098,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693997199,"gmtCreate":1639958684542,"gmtModify":1639958684690,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693997199","repostId":"2192909178","repostType":4,"repost":{"id":"2192909178","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639957864,"share":"https://www.laohu8.com/m/news/2192909178?lang=&edition=full","pubTime":"2021-12-20 07:51","market":"us","language":"en","title":"EU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192909178","media":"Reuters","summary":"Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech ","content":"<p>Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech&nbsp;and Pfizer&nbsp;for an extra 20 million doses of their COVID-19 vaccine to be delivered to EU member states in the first quarter of 2022.</p>\n<p>These doses come on top of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries in the first quarter to 215 million, a commission statement said.</p>\n<p>The commission and member states have also exercised an option to order more than 200 million BioNTech-Pfizer COVID-19 doses adapted for the Omicron variant and expect delivery from the second quarter of 2022.</p>\n<p>These doses would bring the total number of deliveries by BioNTech-Pfizer to 650 million doses during 2022, the commission statement said.</p>\n<p>Governments across Europe are struggling to curb a sharp rise in COVID-19 infections caused by the rapid spread of the newly discovered Omicron coronavirus variant.</p>\n<p>On Dec. 16, the European Commission had said that it has reached an agreement with Moderna&nbsp;to rush deliveries of the U.S. company's COVID-19 vaccine to Germany and other European Union member states.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU secures extra 20 mln Pfizer COVID-19 vaccine doses for Q1 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-20 07:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech&nbsp;and Pfizer&nbsp;for an extra 20 million doses of their COVID-19 vaccine to be delivered to EU member states in the first quarter of 2022.</p>\n<p>These doses come on top of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries in the first quarter to 215 million, a commission statement said.</p>\n<p>The commission and member states have also exercised an option to order more than 200 million BioNTech-Pfizer COVID-19 doses adapted for the Omicron variant and expect delivery from the second quarter of 2022.</p>\n<p>These doses would bring the total number of deliveries by BioNTech-Pfizer to 650 million doses during 2022, the commission statement said.</p>\n<p>Governments across Europe are struggling to curb a sharp rise in COVID-19 infections caused by the rapid spread of the newly discovered Omicron coronavirus variant.</p>\n<p>On Dec. 16, the European Commission had said that it has reached an agreement with Moderna&nbsp;to rush deliveries of the U.S. company's COVID-19 vaccine to Germany and other European Union member states.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4568":"美国抗疫概念","BNTX":"BioNTech SE","BK4007":"制药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192909178","content_text":"Dec 19 (Reuters) - The European Commission said on Sunday it had reached an agreement with BioNTech and Pfizer for an extra 20 million doses of their COVID-19 vaccine to be delivered to EU member states in the first quarter of 2022.\nThese doses come on top of an already scheduled 195 million doses from BioNTech-Pfizer, bringing the total number of deliveries in the first quarter to 215 million, a commission statement said.\nThe commission and member states have also exercised an option to order more than 200 million BioNTech-Pfizer COVID-19 doses adapted for the Omicron variant and expect delivery from the second quarter of 2022.\nThese doses would bring the total number of deliveries by BioNTech-Pfizer to 650 million doses during 2022, the commission statement said.\nGovernments across Europe are struggling to curb a sharp rise in COVID-19 infections caused by the rapid spread of the newly discovered Omicron coronavirus variant.\nOn Dec. 16, the European Commission had said that it has reached an agreement with Moderna to rush deliveries of the U.S. company's COVID-19 vaccine to Germany and other European Union member states.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1450,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699487793,"gmtCreate":1639877538228,"gmtModify":1639877538364,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699487793","repostId":"2192754259","repostType":4,"repost":{"id":"2192754259","kind":"highlight","pubTimestamp":1639811460,"share":"https://www.laohu8.com/m/news/2192754259?lang=&edition=full","pubTime":"2021-12-18 15:11","market":"us","language":"en","title":"Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2192754259","media":"Motley Fool","summary":"Three names you know are trading within 10% of their 52-week lows. They deserve better.","content":"<p>The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily weighted in the market gauges, and we're not just talking about small and obscure names.</p>\n<p><b>Disney</b>&nbsp;(NYSE:DIS),<b> <a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b>&nbsp;(NYSE:TWTR), and <b>Toast </b>(NYSE:TOST) are all trading within 10% of their 52-week lows. They are market leaders, but investors just aren't feeling the love for the entertainment powerhouse, the social media kingmaker, and the toast of the town in restaurant tech. Let's see why these are three promising ideas for the next $5,000 you want to invest in the market.</p>\n<h4><a href=\"https://laohu8.com/S/DIS\">Disney</a></h4>\n<p>Disney's theme parks call themselves the happiest or merriest places on Earth, but shareholders aren't feeling the same way these days. The media maven's stock is less than 5% away from the 52-week low it hit earlier this month.</p>\n<p>It's pretty surprising to see Disney as a market laggard this year. It's the dominant theme park operator and film studio on the planet, making it a clear beneficiary of the reopening of the economy in 2021. Unfortunately for shareholders, things are never as easy as they seem. Disney+ subscriber growth has slowed recently, and that's problematic since the platform for premium streaming video was the major reason for Disney climbing in 2020.</p>\n<p>Disney near 52-week lows is still a sobering development. The theme parks continue to draw. The top movies this year are largely Disney's handiwork. Even its cruise lines are finally sailing again. The weight of the world may be on beleaguered CEO Bob Chapek's shoulders, but it's a small world after all.</p>\n<p><b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b></p>\n<p>Another shocking name skirting fresh lows is Twitter. The company behind the short-form social platform is in a funk, and even the initial 10% pop that the stock experienced after its CEO stepped down late last month proved fleeting. As of Thursday's close, Twitter is also now just 5% above the fresh low it hit two weeks ago.</p>\n<p>The platform is working. Its daily active users have grown 13% over the past year to 211 million. Ad revenue is growing even faster, and that 41% surge is a testament to both Twitter's engagement and its ability to milk more money out of every user. New leadership should help it continue to evolve, and the recent rollout of premium features for those willing to pay a little to improve the experience should get Twitter moving in the right direction again before long.</p>\n<h4><a href=\"https://laohu8.com/S/TOST\">Toast</a></h4>\n<p>Running a restaurant has changed dramatically just in the past couple of years, and Toast is the no-brainer cloud-based platform that keeps eateries on top of all of the trending revenue streams. It's a one-stop shop for restaurant needs. On the consumer-facing end, it helps process mobile ordering for take-out, manage incoming sales from third-party delivery services, and naturally serve as the point-of-sale for in-restaurant dining. It also helps run customer loyalty programs to keep regulars coming back.</p>\n<p>Toast does even more on the enterprise end, tackling everything from payroll to inventory management. With chains and independent concepts emerging smarter out of the pandemic than they were before, the company simplifies the necessary functions of an eatery in the new normal.</p>\n<p>Despite stellar growth -- revenue has soared 105% through the first nine months of this year -- the recent IPO hit an all-time low on Wednesday. It may be causing indigestion for investors who chased the new stock when it popped to double today's price by early November, but right now it feels more like a dinner bell.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 15:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192754259","content_text":"The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily weighted in the market gauges, and we're not just talking about small and obscure names.\nDisney (NYSE:DIS), Twitter (NYSE:TWTR), and Toast (NYSE:TOST) are all trading within 10% of their 52-week lows. They are market leaders, but investors just aren't feeling the love for the entertainment powerhouse, the social media kingmaker, and the toast of the town in restaurant tech. Let's see why these are three promising ideas for the next $5,000 you want to invest in the market.\nDisney\nDisney's theme parks call themselves the happiest or merriest places on Earth, but shareholders aren't feeling the same way these days. The media maven's stock is less than 5% away from the 52-week low it hit earlier this month.\nIt's pretty surprising to see Disney as a market laggard this year. It's the dominant theme park operator and film studio on the planet, making it a clear beneficiary of the reopening of the economy in 2021. Unfortunately for shareholders, things are never as easy as they seem. Disney+ subscriber growth has slowed recently, and that's problematic since the platform for premium streaming video was the major reason for Disney climbing in 2020.\nDisney near 52-week lows is still a sobering development. The theme parks continue to draw. The top movies this year are largely Disney's handiwork. Even its cruise lines are finally sailing again. The weight of the world may be on beleaguered CEO Bob Chapek's shoulders, but it's a small world after all.\nTwitter\nAnother shocking name skirting fresh lows is Twitter. The company behind the short-form social platform is in a funk, and even the initial 10% pop that the stock experienced after its CEO stepped down late last month proved fleeting. As of Thursday's close, Twitter is also now just 5% above the fresh low it hit two weeks ago.\nThe platform is working. Its daily active users have grown 13% over the past year to 211 million. Ad revenue is growing even faster, and that 41% surge is a testament to both Twitter's engagement and its ability to milk more money out of every user. New leadership should help it continue to evolve, and the recent rollout of premium features for those willing to pay a little to improve the experience should get Twitter moving in the right direction again before long.\nToast\nRunning a restaurant has changed dramatically just in the past couple of years, and Toast is the no-brainer cloud-based platform that keeps eateries on top of all of the trending revenue streams. It's a one-stop shop for restaurant needs. On the consumer-facing end, it helps process mobile ordering for take-out, manage incoming sales from third-party delivery services, and naturally serve as the point-of-sale for in-restaurant dining. It also helps run customer loyalty programs to keep regulars coming back.\nToast does even more on the enterprise end, tackling everything from payroll to inventory management. With chains and independent concepts emerging smarter out of the pandemic than they were before, the company simplifies the necessary functions of an eatery in the new normal.\nDespite stellar growth -- revenue has soared 105% through the first nine months of this year -- the recent IPO hit an all-time low on Wednesday. It may be causing indigestion for investors who chased the new stock when it popped to double today's price by early November, but right now it feels more like a dinner bell.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699234886,"gmtCreate":1639806218059,"gmtModify":1639806218223,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699234886","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","kind":"news","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p>\n<p>All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p>\n<p>Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p>\n<p>The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p>\n<p>All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p>\n<p>Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p>\n<p>Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p>\n<p>\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p>\n<p>Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p>\n<p>In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p>\n<p>The Nasdaq Composite dropped 0.07% to 15,169.68.</p>\n<p>On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p>\n<p>With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p>\n<p>For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p>\n<p>In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p>\n<p>FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690491291,"gmtCreate":1639699274511,"gmtModify":1639699274673,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"✅&nbsp;","listText":"✅&nbsp;","text":"✅","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690491291","repostId":"2192920942","repostType":4,"repost":{"id":"2192920942","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639694745,"share":"https://www.laohu8.com/m/news/2192920942?lang=&edition=full","pubTime":"2021-12-17 06:45","market":"us","language":"en","title":"Nasdaq ends sharply lower as investors dump growth stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2192920942","media":"Reuters","summary":"* Fed to end bond purchases, signals rate hikes in 2022\n* Tech is worst among 11 S&P 500 sector inde","content":"<p>* Fed to end bond purchases, signals rate hikes in 2022</p>\n<p>* Tech is worst among 11 S&amp;P 500 sector indexes, financials rally</p>\n<p>* Lennar slips after missing quarterly profit</p>\n<p>* Indexes: Dow -0.08%, S&amp;P 500 -0.87%, Nasdaq -2.47%</p>\n<p>Dec 16 (Reuters) - The Nasdaq ended sharply lower on Thursday as the Federal Reserve's announcement of a faster end to its pandemic-era stimulus pushed investors away from Big Tech and toward more economically sensitive sectors.</p>\n<p>Nvidia,Apple,Microsoft, Amazon&nbsp;and Tesla&nbsp;tumbled between 2.6% and 6.8%, hitting the Nasdaq&nbsp;and the S&amp;P 500, while the Dow Jones Industrial Average declined marginally.</p>\n<p>Most of those heavyweight growth stocks have outperformed the broader market in 2021, with Nvidia up more than 100% year to date.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.08% to end at 35,897.64, while the S&amp;P 500&nbsp;lost 0.87% to 4,668.67.</p>\n<p>The Nasdaq Composite&nbsp;dropped 2.47% to 15,180.44.</p>\n<p>The U.S. central bank said on Wednesday it would end its bond purchases in March and signaled three quarter-percentage-point interest rate hikes by the end of 2022.</p>\n<p>That pleased investors who have increasingly worried about an inflation spike related to the coronavirus pandemic. But on Thursday it contributed to the sell-off in growth stocks.</p>\n<p>The S&amp;P 500 value index&nbsp;climbed 0.7%, while the growth index fell 2.1%, reflecting investors' views that high-growth stocks tend to underperform when interest rates rise. The value index includes stocks seen as more likely to do well during an economic recovery.</p>\n<p>\"You're seeing money come out of growth, as it should. If we are going into an environment where interest rates are going up, growth stocks are going to be less attractive\" said Dennis Dick, a trader at Bright Trading LLC.</p>\n<p>\"There's a lot of uncertainty as we go into 2022... We're going to have a more hawkish Fed that is going to pull away the punch bowl,\" he said.</p>\n<p>Among the 11 major S&amp;P 500 sector indexes, technology&nbsp;slumped 2.9%, while financials&nbsp;rallied 1.2%. Eight of the sectors gained, even as the overall index fell.</p>\n<p>\"The Fed gave the market what it wanted, and today I think investors are turning again to pandemic uncertainty, and they're also cautious going into the end of the year,\" said Lindsey Bell, chief investment strategist at Ally Invest, in Charlotte, North Carolina.</p>\n<p>Recent readings on surging producer and consumer prices, as well as the fast-spreading Omicron variant of the coronavirus, have fueled anxiety. The S&amp;P 500, nonetheless, remains up about 25% in 2021 and it is trading near record highs.</p>\n<p>The CBOE Volatility index, often considered Wall Street's fear gauge, slipped to a three-week low.</p>\n<p>Data showed the number of Americans filing new claims for unemployment benefits increased moderately last week, remaining at levels consistent with tightening labor market conditions.</p>\n<p>Separately, a survey showed production at U.S. factories increased to the highest level in nearly three years in November.</p>\n<p>Lennar Corp&nbsp;fell 4.1% after the homebuilder missed analysts' estimates for quarterly profit as pandemic-led supply chain issues pushed lumber costs higher and delayed house deliveries.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.03-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 69 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 43 new highs and 184 new lows.</p>\n<p>Volume on U.S. exchanges was 11.6 billion shares, in line with the average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq ends sharply lower as investors dump growth stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq ends sharply lower as investors dump growth stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-17 06:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Fed to end bond purchases, signals rate hikes in 2022</p>\n<p>* Tech is worst among 11 S&amp;P 500 sector indexes, financials rally</p>\n<p>* Lennar slips after missing quarterly profit</p>\n<p>* Indexes: Dow -0.08%, S&amp;P 500 -0.87%, Nasdaq -2.47%</p>\n<p>Dec 16 (Reuters) - The Nasdaq ended sharply lower on Thursday as the Federal Reserve's announcement of a faster end to its pandemic-era stimulus pushed investors away from Big Tech and toward more economically sensitive sectors.</p>\n<p>Nvidia,Apple,Microsoft, Amazon&nbsp;and Tesla&nbsp;tumbled between 2.6% and 6.8%, hitting the Nasdaq&nbsp;and the S&amp;P 500, while the Dow Jones Industrial Average declined marginally.</p>\n<p>Most of those heavyweight growth stocks have outperformed the broader market in 2021, with Nvidia up more than 100% year to date.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.08% to end at 35,897.64, while the S&amp;P 500&nbsp;lost 0.87% to 4,668.67.</p>\n<p>The Nasdaq Composite&nbsp;dropped 2.47% to 15,180.44.</p>\n<p>The U.S. central bank said on Wednesday it would end its bond purchases in March and signaled three quarter-percentage-point interest rate hikes by the end of 2022.</p>\n<p>That pleased investors who have increasingly worried about an inflation spike related to the coronavirus pandemic. But on Thursday it contributed to the sell-off in growth stocks.</p>\n<p>The S&amp;P 500 value index&nbsp;climbed 0.7%, while the growth index fell 2.1%, reflecting investors' views that high-growth stocks tend to underperform when interest rates rise. The value index includes stocks seen as more likely to do well during an economic recovery.</p>\n<p>\"You're seeing money come out of growth, as it should. If we are going into an environment where interest rates are going up, growth stocks are going to be less attractive\" said Dennis Dick, a trader at Bright Trading LLC.</p>\n<p>\"There's a lot of uncertainty as we go into 2022... We're going to have a more hawkish Fed that is going to pull away the punch bowl,\" he said.</p>\n<p>Among the 11 major S&amp;P 500 sector indexes, technology&nbsp;slumped 2.9%, while financials&nbsp;rallied 1.2%. Eight of the sectors gained, even as the overall index fell.</p>\n<p>\"The Fed gave the market what it wanted, and today I think investors are turning again to pandemic uncertainty, and they're also cautious going into the end of the year,\" said Lindsey Bell, chief investment strategist at Ally Invest, in Charlotte, North Carolina.</p>\n<p>Recent readings on surging producer and consumer prices, as well as the fast-spreading Omicron variant of the coronavirus, have fueled anxiety. The S&amp;P 500, nonetheless, remains up about 25% in 2021 and it is trading near record highs.</p>\n<p>The CBOE Volatility index, often considered Wall Street's fear gauge, slipped to a three-week low.</p>\n<p>Data showed the number of Americans filing new claims for unemployment benefits increased moderately last week, remaining at levels consistent with tightening labor market conditions.</p>\n<p>Separately, a survey showed production at U.S. factories increased to the highest level in nearly three years in November.</p>\n<p>Lennar Corp&nbsp;fell 4.1% after the homebuilder missed analysts' estimates for quarterly profit as pandemic-led supply chain issues pushed lumber costs higher and delayed house deliveries.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.03-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 69 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 43 new highs and 184 new lows.</p>\n<p>Volume on U.S. exchanges was 11.6 billion shares, in line with the average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","BK4551":"寇图资本持仓","SDOW":"道指三倍做空ETF-ProShares","DXD":"道指两倍做空ETF","AMZN":"亚马逊","LEN":"莱纳建筑公司","OEX":"标普100","BK4561":"索罗斯持仓","TSLA":"特斯拉","BK4505":"高瓴资本持仓","BK4504":"桥水持仓","SDS":"两倍做空标普500ETF","BK4549":"软银资本持仓","BK4088":"住宅建筑","BK4099":"汽车制造商","SSO":"两倍做多标普500ETF","BK4548":"巴美列捷福持仓","TQQQ":"纳指三倍做多ETF","SPXU":"三倍做空标普500ETF","DOG":"道指反向ETF",".IXIC":"NASDAQ Composite","SQQQ":"纳指三倍做空ETF","NVDA":"英伟达","BK4554":"元宇宙及AR概念","BK4515":"5G概念","BK4553":"喜马拉雅资本持仓","OEF":"标普100指数ETF-iShares","BK4534":"瑞士信贷持仓","BK4567":"ESG概念","IVV":"标普500指数ETF","BK4533":"AQR资本管理(全球第二大对冲基金)","SH":"标普500反向ETF","QQQ":"纳指100ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index","BK4524":"宅经济概念","UPRO":"三倍做多标普500ETF","UDOW":"道指三倍做多ETF-ProShares","BK4527":"明星科技股","BK4543":"AI","BK4538":"云计算","BK4559":"巴菲特持仓","BK4501":"段永平概念","PSQ":"纳指反向ETF","DDM":"道指两倍做多ETF","BK4503":"景林资产持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192920942","content_text":"* Fed to end bond purchases, signals rate hikes in 2022\n* Tech is worst among 11 S&P 500 sector indexes, financials rally\n* Lennar slips after missing quarterly profit\n* Indexes: Dow -0.08%, S&P 500 -0.87%, Nasdaq -2.47%\nDec 16 (Reuters) - The Nasdaq ended sharply lower on Thursday as the Federal Reserve's announcement of a faster end to its pandemic-era stimulus pushed investors away from Big Tech and toward more economically sensitive sectors.\nNvidia,Apple,Microsoft, Amazon and Tesla tumbled between 2.6% and 6.8%, hitting the Nasdaq and the S&P 500, while the Dow Jones Industrial Average declined marginally.\nMost of those heavyweight growth stocks have outperformed the broader market in 2021, with Nvidia up more than 100% year to date.\nThe Dow Jones Industrial Average fell 0.08% to end at 35,897.64, while the S&P 500 lost 0.87% to 4,668.67.\nThe Nasdaq Composite dropped 2.47% to 15,180.44.\nThe U.S. central bank said on Wednesday it would end its bond purchases in March and signaled three quarter-percentage-point interest rate hikes by the end of 2022.\nThat pleased investors who have increasingly worried about an inflation spike related to the coronavirus pandemic. But on Thursday it contributed to the sell-off in growth stocks.\nThe S&P 500 value index climbed 0.7%, while the growth index fell 2.1%, reflecting investors' views that high-growth stocks tend to underperform when interest rates rise. The value index includes stocks seen as more likely to do well during an economic recovery.\n\"You're seeing money come out of growth, as it should. If we are going into an environment where interest rates are going up, growth stocks are going to be less attractive\" said Dennis Dick, a trader at Bright Trading LLC.\n\"There's a lot of uncertainty as we go into 2022... We're going to have a more hawkish Fed that is going to pull away the punch bowl,\" he said.\nAmong the 11 major S&P 500 sector indexes, technology slumped 2.9%, while financials rallied 1.2%. Eight of the sectors gained, even as the overall index fell.\n\"The Fed gave the market what it wanted, and today I think investors are turning again to pandemic uncertainty, and they're also cautious going into the end of the year,\" said Lindsey Bell, chief investment strategist at Ally Invest, in Charlotte, North Carolina.\nRecent readings on surging producer and consumer prices, as well as the fast-spreading Omicron variant of the coronavirus, have fueled anxiety. The S&P 500, nonetheless, remains up about 25% in 2021 and it is trading near record highs.\nThe CBOE Volatility index, often considered Wall Street's fear gauge, slipped to a three-week low.\nData showed the number of Americans filing new claims for unemployment benefits increased moderately last week, remaining at levels consistent with tightening labor market conditions.\nSeparately, a survey showed production at U.S. factories increased to the highest level in nearly three years in November.\nLennar Corp fell 4.1% after the homebuilder missed analysts' estimates for quarterly profit as pandemic-led supply chain issues pushed lumber costs higher and delayed house deliveries.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.03-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored decliners.\nThe S&P 500 posted 69 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 43 new highs and 184 new lows.\nVolume on U.S. exchanges was 11.6 billion shares, in line with the average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690000835,"gmtCreate":1639610763134,"gmtModify":1639610763312,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690000835","repostId":"2191994940","repostType":4,"repost":{"id":"2191994940","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639608624,"share":"https://www.laohu8.com/m/news/2191994940?lang=&edition=full","pubTime":"2021-12-16 06:50","market":"us","language":"en","title":"Wall St ends higher; Fed to end bond purchases in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2191994940","media":"Reuters","summary":"Fed says it will end bond purchases in March\nTech and healthcare the strongest sectors\nIndexes: Dow ","content":"<ul>\n <li>Fed says it will end bond purchases in March</li>\n <li>Tech and healthcare the strongest sectors</li>\n <li>Indexes: Dow +1.08%, S&amp;P 500 +1.63%, Nasdaq +2.15%</li>\n</ul>\n<p>Dec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.</p>\n<p>Following its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.</p>\n<p>All three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an&nbsp;upbeat tone&nbsp;about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.</p>\n<p>\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"</p>\n<p>The S&amp;P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.</p>\n<p>For the session, the Dow Jones Industrial Average&nbsp;rose 1.08% to end at 35,927.43 points, while the S&amp;P 500&nbsp;gained 1.63% to 4,709.85.</p>\n<p>The Nasdaq Composite&nbsp;climbed 2.15% to 15,565.58.</p>\n<p>Volume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.</p>\n<p>Inflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.</p>\n<p>\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"</p>\n<p>Among the 11 S&amp;P 500 sector indexes, technology&nbsp;jumped 2.7% and healthcare&nbsp;rallied 2.1%.</p>\n<p>Apple Inc&nbsp;climbed 2.85% and Nvidia Corp&nbsp;rallied 7.49%, with both lifting the S&amp;P 500 more than any other stocks.</p>\n<p>The Philadelphia Semiconductor index&nbsp;jumped 3.7%.</p>\n<p>Albemarle Corp&nbsp;ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St ends higher; Fed to end bond purchases in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St ends higher; Fed to end bond purchases in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-16 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Fed says it will end bond purchases in March</li>\n <li>Tech and healthcare the strongest sectors</li>\n <li>Indexes: Dow +1.08%, S&amp;P 500 +1.63%, Nasdaq +2.15%</li>\n</ul>\n<p>Dec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.</p>\n<p>Following its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.</p>\n<p>All three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an&nbsp;upbeat tone&nbsp;about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.</p>\n<p>\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"</p>\n<p>The S&amp;P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.</p>\n<p>For the session, the Dow Jones Industrial Average&nbsp;rose 1.08% to end at 35,927.43 points, while the S&amp;P 500&nbsp;gained 1.63% to 4,709.85.</p>\n<p>The Nasdaq Composite&nbsp;climbed 2.15% to 15,565.58.</p>\n<p>Volume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.</p>\n<p>Inflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.</p>\n<p>\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"</p>\n<p>Among the 11 S&amp;P 500 sector indexes, technology&nbsp;jumped 2.7% and healthcare&nbsp;rallied 2.1%.</p>\n<p>Apple Inc&nbsp;climbed 2.85% and Nvidia Corp&nbsp;rallied 7.49%, with both lifting the S&amp;P 500 more than any other stocks.</p>\n<p>The Philadelphia Semiconductor index&nbsp;jumped 3.7%.</p>\n<p>Albemarle Corp&nbsp;ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达",".SPX":"S&P 500 Index","AAPL":"苹果",".IXIC":"NASDAQ Composite","ALB":"美国雅保",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191994940","content_text":"Fed says it will end bond purchases in March\nTech and healthcare the strongest sectors\nIndexes: Dow +1.08%, S&P 500 +1.63%, Nasdaq +2.15%\n\nDec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.\nFollowing its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.\nAll three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an upbeat tone about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.\n\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"\nThe S&P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.\nFor the session, the Dow Jones Industrial Average rose 1.08% to end at 35,927.43 points, while the S&P 500 gained 1.63% to 4,709.85.\nThe Nasdaq Composite climbed 2.15% to 15,565.58.\nVolume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.\nInflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.\n\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"\nAmong the 11 S&P 500 sector indexes, technology jumped 2.7% and healthcare rallied 2.1%.\nApple Inc climbed 2.85% and Nvidia Corp rallied 7.49%, with both lifting the S&P 500 more than any other stocks.\nThe Philadelphia Semiconductor index jumped 3.7%.\nAlbemarle Corp ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"\nAdvancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.\nThe S&P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":956,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604959936,"gmtCreate":1639316957324,"gmtModify":1639316957446,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604959936","repostId":"2190679207","repostType":4,"repost":{"id":"2190679207","kind":"highlight","pubTimestamp":1639281804,"share":"https://www.laohu8.com/m/news/2190679207?lang=&edition=full","pubTime":"2021-12-12 12:03","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2190679207","media":"Motley Fool","summary":"These two stocks could change your retirement.","content":"<p>Over the past 15 years, the <b>S&amp;P 500</b> has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.</p>\n<p>While this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think <b>Latch</b> (NASDAQ:LTCH) and <b>Lemonade</b> (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.</p>\n<h2>1. Latch: Smart security</h2>\n<p>This smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on <a href=\"https://laohu8.com/S/AONE.U\">one</a> platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.</p>\n<p>Nearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.</p>\n<p>Latch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.</p>\n<p>Latch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like <b>Brookfield</b> (NYSE:BAM) and <b>Avalon Bay</b> (NYSE:AVB).</p>\n<p>This company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>Q3 2020</th>\n   <th>Q3 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$15.9 million</td>\n   <td>$34.2 million</td>\n   <td>115%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>311.5%</td>\n   <td>305.7%</td>\n   <td>N/A</td>\n  </tr>\n </tbody>\n</table>\n<p>The company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.</p>\n<p>Also, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.</p>\n<h2>2. Lemonade: An insurance provider anyone can love</h2>\n<p>Lemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.</p>\n<p>Lemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.</p>\n<p>The company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>First Nine Months of 2020</th>\n   <th>First Nine Months of 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$88.4 million</td>\n   <td>$171.0 million</td>\n   <td>93.4%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>119.6%</td>\n   <td>195.6%</td>\n   <td><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>This major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.</p>\n<p>Lemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.</p>\n<p>Both of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 12:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4543":"AI","AVB":"阿湾物产","AI":"C3.ai, Inc.","BK4548":"巴美列捷福持仓","ESG":"FlexShares STOXX US ESG Select Index Fund","BK4107":"财产与意外伤害保险","LTCH":"Latch, Inc.","BK4528":"SaaS概念","BK4535":"淡马锡持仓","BK4135":"资产管理与托管银行","BK4023":"应用软件","BK4549":"软银资本持仓","BAM":"布鲁克菲尔德资产管理","BK4551":"寇图资本持仓","LMND":"Lemonade, Inc.","BK4215":"住宅房地产投资信托"},"source_url":"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190679207","content_text":"Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.\nWhile this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think Latch (NASDAQ:LTCH) and Lemonade (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.\n1. Latch: Smart security\nThis smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on one platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.\nNearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.\nLatch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.\nLatch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like Brookfield (NYSE:BAM) and Avalon Bay (NYSE:AVB).\nThis company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.\n\n\n\nMetric\nQ3 2020\nQ3 2021\nChange\n\n\nNet loss\n$15.9 million\n$34.2 million\n115%\n\n\nNet loss as a percentage of revenue\n311.5%\n305.7%\nN/A\n\n\n\nThe company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.\nAlso, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.\n2. Lemonade: An insurance provider anyone can love\nLemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.\nLemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.\nThe company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.\n\n\n\nMetric\nFirst Nine Months of 2020\nFirst Nine Months of 2021\nChange\n\n\nNet loss\n$88.4 million\n$171.0 million\n93.4%\n\n\nNet loss as a percentage of revenue\n119.6%\n195.6%\nN/A\n\n\n\nThis major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.\nLemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.\nBoth of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1152,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605565797,"gmtCreate":1639193009819,"gmtModify":1639193009969,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605565797","repostId":"2190205546","repostType":4,"repost":{"id":"2190205546","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639186643,"share":"https://www.laohu8.com/m/news/2190205546?lang=&edition=full","pubTime":"2021-12-11 09:37","market":"us","language":"en","title":"GM eyes $3 billion in investment in Michigan EV plants - source","url":"https://stock-news.laohu8.com/highlight/detail?id=2190205546","media":"Reuters","summary":"Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilit","content":"<p>Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, <a href=\"https://laohu8.com/S/AONE.U\">one</a> with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.</p>\n<p>If approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.</p>\n<p>GM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.</p>\n<p>The cost of the Lansing battery plant would be shared with LGES.</p>\n<p>The Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GM eyes $3 billion in investment in Michigan EV plants - source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGM eyes $3 billion in investment in Michigan EV plants - source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 09:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, <a href=\"https://laohu8.com/S/AONE.U\">one</a> with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.</p>\n<p>If approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.</p>\n<p>GM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.</p>\n<p>The cost of the Lansing battery plant would be shared with LGES.</p>\n<p>The Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4555":"新能源车","GM":"通用汽车","BK4566":"资本集团","BK4099":"汽车制造商","BK4561":"索罗斯持仓","BK4559":"巴菲特持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190205546","content_text":"Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, one with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.\nIf approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.\nGM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.\nThe cost of the Lansing battery plant would be shared with LGES.\nThe Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1038,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605061915,"gmtCreate":1639094155437,"gmtModify":1639094155546,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/605061915","repostId":"1155710066","repostType":4,"repost":{"id":"1155710066","kind":"news","pubTimestamp":1639092826,"share":"https://www.laohu8.com/m/news/1155710066?lang=&edition=full","pubTime":"2021-12-10 07:33","market":"us","language":"en","title":"Chewy stock slides as supply chain challenges and labor shortages cause earnings miss","url":"https://stock-news.laohu8.com/highlight/detail?id=1155710066","media":"seekingalpha","summary":"Chewy, Inc.(NYSE:CHWY)shares drop as the company's net loss nearly doubled from the prior quarter an","content":"<p>Chewy, Inc.(NYSE:CHWY)shares drop as the company's net loss nearly doubled from the prior quarter and FQ3 EPS werebelow expectations.&nbsp;Net loss was ($32.2M) for the quarter ended Oct. 31, 2021 compared to ($16.7M) in FQ2 2021.</p>\n<p>Revenue grew 24.1% Y/Y and gross margin expanded 90 bps to 26.4%. Compared to Q2 2021, revenue grew 2.3% and gross margin fell 110 bps.</p>\n<p>The company's active customer base jumped 1.5% Q/Q (+14.7% Y/Y) while net sales per active customer increased by $15 from Q2 2021 (+$56 Y/Y).</p>\n<p>\"Our third-quarter profitability reflects the impact of ongoing supply chain disruptions, labor shortages, and higher inflation,\" said CEO&nbsp;Sumit Singh.</p>\n<p>Shares are&nbsp;down&nbsp;nearly 8%&nbsp;AH.</p>\n<p>This is Chewy's second consecutive earnings miss after over a year of&nbsp;earnings beats.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chewy stock slides as supply chain challenges and labor shortages cause earnings miss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChewy stock slides as supply chain challenges and labor shortages cause earnings miss\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3778933-chewy-stock-slides-as-supply-chain-challenges-and-labor-shortages-cause-earnings-miss><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chewy, Inc.(NYSE:CHWY)shares drop as the company's net loss nearly doubled from the prior quarter and FQ3 EPS werebelow expectations. Net loss was ($32.2M) for the quarter ended Oct. 31, 2021 compared...</p>\n\n<a href=\"https://seekingalpha.com/news/3778933-chewy-stock-slides-as-supply-chain-challenges-and-labor-shortages-cause-earnings-miss\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3778933-chewy-stock-slides-as-supply-chain-challenges-and-labor-shortages-cause-earnings-miss","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1155710066","content_text":"Chewy, Inc.(NYSE:CHWY)shares drop as the company's net loss nearly doubled from the prior quarter and FQ3 EPS werebelow expectations. Net loss was ($32.2M) for the quarter ended Oct. 31, 2021 compared to ($16.7M) in FQ2 2021.\nRevenue grew 24.1% Y/Y and gross margin expanded 90 bps to 26.4%. Compared to Q2 2021, revenue grew 2.3% and gross margin fell 110 bps.\nThe company's active customer base jumped 1.5% Q/Q (+14.7% Y/Y) while net sales per active customer increased by $15 from Q2 2021 (+$56 Y/Y).\n\"Our third-quarter profitability reflects the impact of ongoing supply chain disruptions, labor shortages, and higher inflation,\" said CEO Sumit Singh.\nShares are down nearly 8% AH.\nThis is Chewy's second consecutive earnings miss after over a year of earnings beats.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1265,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602811656,"gmtCreate":1639006398003,"gmtModify":1639006398152,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602811656","repostId":"2190954616","repostType":4,"repost":{"id":"2190954616","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1639005120,"share":"https://www.laohu8.com/m/news/2190954616?lang=&edition=full","pubTime":"2021-12-09 07:12","market":"us","language":"en","title":"RH stock rallies following earnings beat, raised outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2190954616","media":"Dow Jones","summary":"RH shares rallied in the extended session Wednesday after the retailer formerly known as Restoration","content":"<p>RH shares rallied in the extended session Wednesday after the retailer formerly known as Restoration Hardware topped Wall Street expectations for the quarter and raised its forecast to match the consensus estimated by analysts.</p>\n<p>RH <a href=\"https://laohu8.com/S/RH\">$(RH)$</a> shares surged 11% after hours, following a 0.1% rise in the regular session to close at $576.96. Shares are up 22% over the past 12 months, compared with a 27% gain by the S&amp;P 500 index .</p>\n<p>The company reported third-quarter net income of $184.1 million, or $5.88 a share, compared with $46.4 million, or $1.64 a share, in the year-ago period. Adjusted earnings were $7.03 a share, compared with $6.20 a share in the year-ago period.</p>\n<p>Revenue rose to $1.01 billion from $844 million in the year-ago quarter.</p>\n<p>Analysts surveyed by FactSet had forecast earnings of $6.61 a share on revenue of $981.9 million.</p>\n<p>\"While we believe a conservative view of revenues in the fourth quarter is prudent due to the uncertainties posed by the new virus variant, the postponed opening of our new San Francisco Gallery until the spring, and the continued shipping and port delays, the power of our operating model gives us the confidence to raise our outlook for fiscal 2021 for the third time this year,\" the company said in a statement.</p>\n<p>RH expects fiscal 2021 revenue growth of between 32% and 33%, or $3.76 billion to $3.79 billion. Previously, RH had forecast a 31% to %33 gain. Analysts expect revenue of $3.76 billion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RH stock rallies following earnings beat, raised outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRH stock rallies following earnings beat, raised outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-09 07:12</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>RH shares rallied in the extended session Wednesday after the retailer formerly known as Restoration Hardware topped Wall Street expectations for the quarter and raised its forecast to match the consensus estimated by analysts.</p>\n<p>RH <a href=\"https://laohu8.com/S/RH\">$(RH)$</a> shares surged 11% after hours, following a 0.1% rise in the regular session to close at $576.96. Shares are up 22% over the past 12 months, compared with a 27% gain by the S&amp;P 500 index .</p>\n<p>The company reported third-quarter net income of $184.1 million, or $5.88 a share, compared with $46.4 million, or $1.64 a share, in the year-ago period. Adjusted earnings were $7.03 a share, compared with $6.20 a share in the year-ago period.</p>\n<p>Revenue rose to $1.01 billion from $844 million in the year-ago quarter.</p>\n<p>Analysts surveyed by FactSet had forecast earnings of $6.61 a share on revenue of $981.9 million.</p>\n<p>\"While we believe a conservative view of revenues in the fourth quarter is prudent due to the uncertainties posed by the new virus variant, the postponed opening of our new San Francisco Gallery until the spring, and the continued shipping and port delays, the power of our operating model gives us the confidence to raise our outlook for fiscal 2021 for the third time this year,\" the company said in a statement.</p>\n<p>RH expects fiscal 2021 revenue growth of between 32% and 33%, or $3.76 billion to $3.79 billion. Previously, RH had forecast a 31% to %33 gain. Analysts expect revenue of $3.76 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RH":"Restoration Hardware Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190954616","content_text":"RH shares rallied in the extended session Wednesday after the retailer formerly known as Restoration Hardware topped Wall Street expectations for the quarter and raised its forecast to match the consensus estimated by analysts.\nRH $(RH)$ shares surged 11% after hours, following a 0.1% rise in the regular session to close at $576.96. Shares are up 22% over the past 12 months, compared with a 27% gain by the S&P 500 index .\nThe company reported third-quarter net income of $184.1 million, or $5.88 a share, compared with $46.4 million, or $1.64 a share, in the year-ago period. Adjusted earnings were $7.03 a share, compared with $6.20 a share in the year-ago period.\nRevenue rose to $1.01 billion from $844 million in the year-ago quarter.\nAnalysts surveyed by FactSet had forecast earnings of $6.61 a share on revenue of $981.9 million.\n\"While we believe a conservative view of revenues in the fourth quarter is prudent due to the uncertainties posed by the new virus variant, the postponed opening of our new San Francisco Gallery until the spring, and the continued shipping and port delays, the power of our operating model gives us the confidence to raise our outlook for fiscal 2021 for the third time this year,\" the company said in a statement.\nRH expects fiscal 2021 revenue growth of between 32% and 33%, or $3.76 billion to $3.79 billion. Previously, RH had forecast a 31% to %33 gain. Analysts expect revenue of $3.76 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":800,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606477784,"gmtCreate":1638924569649,"gmtModify":1638924569830,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606477784","repostId":"2189659812","repostType":4,"repost":{"id":"2189659812","kind":"news","pubTimestamp":1638923767,"share":"https://www.laohu8.com/m/news/2189659812?lang=&edition=full","pubTime":"2021-12-08 08:36","market":"us","language":"en","title":"Pfizer, ex-employee reach accord over Covid-19 vaccine secrets","url":"https://stock-news.laohu8.com/highlight/detail?id=2189659812","media":"The Straits Times","summary":"NEW YORK (REUTERS) - Pfizer has reached a truce with a former longtime employee whom it sued two wee","content":"<div>\n<p>NEW YORK (REUTERS) - Pfizer has reached a truce with a former longtime employee whom it sued two weeks ago for allegedly stealing confidential documents related to its Covid-19 vaccine and other drugs...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/pfizer-ex-employee-reach-accord-over-covid-19-vaccine-secrets\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, ex-employee reach accord over Covid-19 vaccine secrets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, ex-employee reach accord over Covid-19 vaccine secrets\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 08:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/world/united-states/pfizer-ex-employee-reach-accord-over-covid-19-vaccine-secrets><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (REUTERS) - Pfizer has reached a truce with a former longtime employee whom it sued two weeks ago for allegedly stealing confidential documents related to its Covid-19 vaccine and other drugs...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/pfizer-ex-employee-reach-accord-over-covid-19-vaccine-secrets\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"http://www.straitstimes.com/world/united-states/pfizer-ex-employee-reach-accord-over-covid-19-vaccine-secrets","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189659812","content_text":"NEW YORK (REUTERS) - Pfizer has reached a truce with a former longtime employee whom it sued two weeks ago for allegedly stealing confidential documents related to its Covid-19 vaccine and other drugs.\nUnder an agreement filed on Monday (Dec 6), Li Chunxiao, a former associate director of statistics and 15-year Pfizer veteran, will let Pfizer's lawyers review her computers and online accounts for the drugmaker's confidential information.\nPfizer is expected to complete that review by Dec 29, when Ms Li must also submit a sworn declaration that she no longer possesses its confidential information or trade secrets.\nThe drugmaker's lawsuit in San Diego federal court could end in early January if the conditions are met.\nMr Adam Cashman, a lawyer for Ms Li, declined to comment on Tuesday.\nPfizer, based in New York, had sued Ms Li on Nov 23, saying she had uploaded more than 12,000 files without permission from her company-issued laptop as she was preparing to join another company.\nIt said the files included a \"playbook\" discussing the Pfizer-BioNTech Covid-19 vaccine, Pfizer's relationship with its German vaccine partner and presentations related to cancer antibodies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606191546,"gmtCreate":1638840588629,"gmtModify":1638840588774,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606191546","repostId":"1185587293","repostType":4,"isVote":1,"tweetType":1,"viewCount":170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608256261,"gmtCreate":1638751869204,"gmtModify":1638751869279,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/608256261","repostId":"1156601067","repostType":4,"isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608062717,"gmtCreate":1638582904148,"gmtModify":1638582904267,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608062717","repostId":"1162832222","repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"tweetType":1,"viewCount":348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601396343,"gmtCreate":1638489687980,"gmtModify":1638489687980,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/601396343","repostId":"2188510525","repostType":4,"repost":{"id":"2188510525","kind":"news","pubTimestamp":1638480363,"share":"https://www.laohu8.com/m/news/2188510525?lang=&edition=full","pubTime":"2021-12-03 05:26","market":"us","language":"en","title":"US STOCKS-Wall Street ends higher in robust rebound from Omicron-driven rout","url":"https://stock-news.laohu8.com/highlight/detail?id=2188510525","media":"Reuters","summary":"A broad rally sent Wall Street to a sharply higher close on Thursday, recovering ground lost over re","content":"<p>A broad rally sent Wall Street to a sharply higher close on Thursday, recovering ground lost over recent sessions as market participants snapped up bargains while digesting the implications of a shifting pandemic.</p>\n<p>All three U.S. indexes advanced, with investors favoring value over growth, and economically sensitive smallcaps and transports outperforming the broader market.</p>\n<p>Of the three, the Dow gained the most, notching its highest <a href=\"https://laohu8.com/S/AONE.U\">one</a>-day percentage gain since March 5, with Boeing Co providing the biggest lift to the blue-chip industrial average.</p>\n<p>\"We went 29 days in a row in the S&amp;P 500 without a 1% change, up or down, but boom - Omicron hits and five days we’ve had this blast of volatility,\" said Ryan Detrick, chief market strategist at LPL Financial in Charlotte, North Carolina.</p>\n<p>\"After the worst two-day drop in more than a year, we’re finally seeing a bit of a bounce,\" Detrick added. \"Buyers are starting to nibble after the recent weakness and pushed stocks higher, but the uncertainty of Omicron is still out there.\"</p>\n<p>As world governments scramble to determine how to respond to the emergent COVID-19 Omicron variant, the United States is set to require private health insurance companies to provide at-home tests, a policy expected to go into effect on Jan. 15.</p>\n<p>The Omicron variant has spooked markets for about a week, hitting travel-related stocks particularly hard as a patchwork of new restrictions were enacted around the globe, but those companies were bouncing back in Thursday's session.</p>\n<p>The S&amp;P 1500 Airlines and Hotel and Restaurants indexes jumped 7.5% and 3.8%, respectively.</p>\n<p>It was the S&amp;P 1500 Airlines index's best one-day performance since Nov. 9, 2020, when Pfizer Inc announced the vaccine it developed with BioNTech was more than 90% effective in preventing COVID-19 infection.</p>\n<p>Jobless claims and planned layoffs data provided further evidence that employers are increasingly disinclined to hand out pink slips amid a tight labor market, the result of booming demand colliding with worker scarcity and low labor market participation.</p>\n<p>Labor scarcity, combined with stubbornly persistent supply chain constraints, has helped erase the word \"transitory\" from the Federal Reserve's inflation vocabulary as wages and prices continue to rise, and could very well translate into rate hikes coming sooner and faster than many had hoped.</p>\n<p>Market participants now train their gaze on the Labor Department's hotly anticipated November employment report, expected on Friday.</p>\n<p>\"We're optimistic we’ll have another strong number, suggesting the economy continues to be on very firm footing,\" Detrick added. \"We’re watching wage growth for any hints of potential inflationary worries.\"</p>\n<p>The Dow Jones Industrial Average rose 617.75 points, or 1.82%, to 34,639.79, the S&amp;P 500 gained 64.06 points, or 1.42%, to 4,577.1 and the Nasdaq Composite added 127.27 points, or 0.83%, to 15,381.32.</p>\n<p>All 11 major sectors of the S&amp;P 500 closed in positive territory, with industrials, energy and financials enjoying the biggest percentage gains.</p>\n<p>Boeing shares had their best day since Feb. 24, jumping 7.5% after China's aviation authority gave its seal of approval the planemaker's 737 MAX aircraft.</p>\n<p>Grocery retailer Kroger Co raised its full-year sales and profit forecasts, sending its stock bounding 11% higher.</p>\n<p>Consumer credit companies <a href=\"https://laohu8.com/S/V\">Visa</a> Inc, Mastercard Inc and American Express Co all advanced more than 4%.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.49-to-1 ratio; on Nasdaq, a 1.79-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted four new 52-week highs and 12 new lows; the Nasdaq Composite recorded 15 new highs and 559 new lows.</p>\n<p>Volume on U.S. exchanges was 12.85 billion shares, compared with the 11.40 billion average over the last 20 trading days. (Reporting by Stephen Culp; additional reporting by Devik Jain and Anisha Sircar in Bengaluru Editing by Marguerita Choy)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Wall Street ends higher in robust rebound from Omicron-driven rout</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Wall Street ends higher in robust rebound from Omicron-driven rout\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 05:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-ends-212603535.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A broad rally sent Wall Street to a sharply higher close on Thursday, recovering ground lost over recent sessions as market participants snapped up bargains while digesting the implications of a ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212603535.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4079":"房地产服务","BA":"波音","BK4539":"次新股","COMP":"Compass, Inc.","BK4516":"特朗普概念","BK4187":"航天航空与国防","BK4564":"太空概念","BK4551":"寇图资本持仓"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212603535.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2188510525","content_text":"A broad rally sent Wall Street to a sharply higher close on Thursday, recovering ground lost over recent sessions as market participants snapped up bargains while digesting the implications of a shifting pandemic.\nAll three U.S. indexes advanced, with investors favoring value over growth, and economically sensitive smallcaps and transports outperforming the broader market.\nOf the three, the Dow gained the most, notching its highest one-day percentage gain since March 5, with Boeing Co providing the biggest lift to the blue-chip industrial average.\n\"We went 29 days in a row in the S&P 500 without a 1% change, up or down, but boom - Omicron hits and five days we’ve had this blast of volatility,\" said Ryan Detrick, chief market strategist at LPL Financial in Charlotte, North Carolina.\n\"After the worst two-day drop in more than a year, we’re finally seeing a bit of a bounce,\" Detrick added. \"Buyers are starting to nibble after the recent weakness and pushed stocks higher, but the uncertainty of Omicron is still out there.\"\nAs world governments scramble to determine how to respond to the emergent COVID-19 Omicron variant, the United States is set to require private health insurance companies to provide at-home tests, a policy expected to go into effect on Jan. 15.\nThe Omicron variant has spooked markets for about a week, hitting travel-related stocks particularly hard as a patchwork of new restrictions were enacted around the globe, but those companies were bouncing back in Thursday's session.\nThe S&P 1500 Airlines and Hotel and Restaurants indexes jumped 7.5% and 3.8%, respectively.\nIt was the S&P 1500 Airlines index's best one-day performance since Nov. 9, 2020, when Pfizer Inc announced the vaccine it developed with BioNTech was more than 90% effective in preventing COVID-19 infection.\nJobless claims and planned layoffs data provided further evidence that employers are increasingly disinclined to hand out pink slips amid a tight labor market, the result of booming demand colliding with worker scarcity and low labor market participation.\nLabor scarcity, combined with stubbornly persistent supply chain constraints, has helped erase the word \"transitory\" from the Federal Reserve's inflation vocabulary as wages and prices continue to rise, and could very well translate into rate hikes coming sooner and faster than many had hoped.\nMarket participants now train their gaze on the Labor Department's hotly anticipated November employment report, expected on Friday.\n\"We're optimistic we’ll have another strong number, suggesting the economy continues to be on very firm footing,\" Detrick added. \"We’re watching wage growth for any hints of potential inflationary worries.\"\nThe Dow Jones Industrial Average rose 617.75 points, or 1.82%, to 34,639.79, the S&P 500 gained 64.06 points, or 1.42%, to 4,577.1 and the Nasdaq Composite added 127.27 points, or 0.83%, to 15,381.32.\nAll 11 major sectors of the S&P 500 closed in positive territory, with industrials, energy and financials enjoying the biggest percentage gains.\nBoeing shares had their best day since Feb. 24, jumping 7.5% after China's aviation authority gave its seal of approval the planemaker's 737 MAX aircraft.\nGrocery retailer Kroger Co raised its full-year sales and profit forecasts, sending its stock bounding 11% higher.\nConsumer credit companies Visa Inc, Mastercard Inc and American Express Co all advanced more than 4%.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.49-to-1 ratio; on Nasdaq, a 1.79-to-1 ratio favored advancers.\nThe S&P 500 posted four new 52-week highs and 12 new lows; the Nasdaq Composite recorded 15 new highs and 559 new lows.\nVolume on U.S. exchanges was 12.85 billion shares, compared with the 11.40 billion average over the last 20 trading days. (Reporting by Stephen Culp; additional reporting by Devik Jain and Anisha Sircar in Bengaluru Editing by Marguerita Choy)","news_type":1},"isVote":1,"tweetType":1,"viewCount":302,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603639674,"gmtCreate":1638404050204,"gmtModify":1638404050379,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/603639674","repostId":"2188949564","repostType":4,"repost":{"id":"2188949564","kind":"news","pubTimestamp":1638403304,"share":"https://www.laohu8.com/m/news/2188949564?lang=&edition=full","pubTime":"2021-12-02 08:01","market":"us","language":"en","title":"26 cheap stocks to buy now that Omicron has hammered markets: Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2188949564","media":"Yahoo Finance","summary":"It could be time to do some holiday shopping not at the malls but in the bruised stock market, opine","content":"<p>It could be time to do some holiday shopping not at the malls but in the bruised stock market, opines Wells Fargo's senior equity analyst Chris Harvey.</p>\n<p>\"It might be a little early to buy the stock market, but perhaps a few \"Black Friday discounts\" are ready for the shopping cart,\" said Harvey in a research note titled \"Holiday Sale!\" Wednesday.</p>\n<p>Harvey lists 26 stocks (see list below) as potential buys right now, headlined by American Express, Ralph Lauren, <a href=\"https://laohu8.com/S/EXPE\">Expedia</a>, Hyatt Hotels and Schlumberger.</p>\n<p>All the stocks on the suggested list boast the following key criteria for Harvey: (1) all rated Overweight (Buy) by Wells Fargo's analysts; (2) the stocks are down 10% or more since Nov. 8; they have positive long-term momentum; a reasonable net debt to EBITDA ratio (earnings before interest, taxes, depreciation and amortization); quality return on equity ratio; and a market cap of at least $3 billion.</p>\n<p>Adds Harvey, \"For the first time since the market began to fade, we believe the real holiday sales may not be online or at the mall, but rather in the stock market.\"</p>\n<p><img src=\"https://static.tigerbbs.com/7b25a901c3ab425e277be287013b6e7b\" tg-width=\"898\" tg-height=\"744\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Wells Fargo releases a helpful list of potential stocks to buy now that markets are off their highs.Wells Fargo</p>\n<p>The buy list from Harvey comes as markets continue to endure a turbulent stretch, which began with an awful 1,000-plus point loss for the Dow Jones Industrial Average on the day after Thanksgiving.</p>\n<p>The Dow Jones Industrial Average plunged 652 points in Tuesday trading, while the Nasdaq Composite and S&amp;P 500 were also deeply in the red. All 30 Dow components were in the red for the session, except for Apple and Merck.</p>\n<p>Stocks were clobbered by the <a href=\"https://laohu8.com/S/AONE.U\">one</a>-two punch of Omicron variant concerns and surprisingly hawkish testimony to lawmakers by Federal Reserve Chairman Jerome Powell.</p>\n<p>\"This tone is completely different than anything he has used over the past three years … and that, in and by itself, equates to a significant change in policy by the chairman and the Federal Reserve as a whole. In other words, the 'gradualism' that the Fed has been using all year is gone. Therefore, the way that investors should be looking at the strategy of 'Don’t fight the Fed' has changed in a substantial way this week,\" said Matt Maley, Miller Tabak chief markets strategist.</p>\n<p>Markets tried to stage a comeback Wednesday, but by afternoon trading stocks were well off their highs of the session after the U.S. confirmed its first case of the Omicron variant as Yahoo Finance's Emily McCormick reports.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>26 cheap stocks to buy now that Omicron has hammered markets: Wells Fargo</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n26 cheap stocks to buy now that Omicron has hammered markets: Wells Fargo\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 08:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/26-cheap-stocks-to-buy-now-that-omicron-has-hammered-markets-wells-fargo-191634430.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It could be time to do some holiday shopping not at the malls but in the bruised stock market, opines Wells Fargo's senior equity analyst Chris Harvey.\n\"It might be a little early to buy the stock ...</p>\n\n<a href=\"https://finance.yahoo.com/news/26-cheap-stocks-to-buy-now-that-omicron-has-hammered-markets-wells-fargo-191634430.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WFC":"富国银行","BK4559":"巴菲特持仓","BK4501":"段永平概念","RL":"拉夫劳伦","FOXA":"福克斯-A","BK4504":"桥水持仓","H":"凯悦酒店","SLB":"斯伦贝谢","EXPE":"Expedia","AXP":"美国运通","BK4207":"综合性银行","HES":"赫斯","FOX":"福克斯-B"},"source_url":"https://finance.yahoo.com/news/26-cheap-stocks-to-buy-now-that-omicron-has-hammered-markets-wells-fargo-191634430.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2188949564","content_text":"It could be time to do some holiday shopping not at the malls but in the bruised stock market, opines Wells Fargo's senior equity analyst Chris Harvey.\n\"It might be a little early to buy the stock market, but perhaps a few \"Black Friday discounts\" are ready for the shopping cart,\" said Harvey in a research note titled \"Holiday Sale!\" Wednesday.\nHarvey lists 26 stocks (see list below) as potential buys right now, headlined by American Express, Ralph Lauren, Expedia, Hyatt Hotels and Schlumberger.\nAll the stocks on the suggested list boast the following key criteria for Harvey: (1) all rated Overweight (Buy) by Wells Fargo's analysts; (2) the stocks are down 10% or more since Nov. 8; they have positive long-term momentum; a reasonable net debt to EBITDA ratio (earnings before interest, taxes, depreciation and amortization); quality return on equity ratio; and a market cap of at least $3 billion.\nAdds Harvey, \"For the first time since the market began to fade, we believe the real holiday sales may not be online or at the mall, but rather in the stock market.\"\nWells Fargo releases a helpful list of potential stocks to buy now that markets are off their highs.Wells Fargo\nThe buy list from Harvey comes as markets continue to endure a turbulent stretch, which began with an awful 1,000-plus point loss for the Dow Jones Industrial Average on the day after Thanksgiving.\nThe Dow Jones Industrial Average plunged 652 points in Tuesday trading, while the Nasdaq Composite and S&P 500 were also deeply in the red. All 30 Dow components were in the red for the session, except for Apple and Merck.\nStocks were clobbered by the one-two punch of Omicron variant concerns and surprisingly hawkish testimony to lawmakers by Federal Reserve Chairman Jerome Powell.\n\"This tone is completely different than anything he has used over the past three years … and that, in and by itself, equates to a significant change in policy by the chairman and the Federal Reserve as a whole. In other words, the 'gradualism' that the Fed has been using all year is gone. Therefore, the way that investors should be looking at the strategy of 'Don’t fight the Fed' has changed in a substantial way this week,\" said Matt Maley, Miller Tabak chief markets strategist.\nMarkets tried to stage a comeback Wednesday, but by afternoon trading stocks were well off their highs of the session after the U.S. confirmed its first case of the Omicron variant as Yahoo Finance's Emily McCormick reports.","news_type":1},"isVote":1,"tweetType":1,"viewCount":316,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609413343,"gmtCreate":1638316953505,"gmtModify":1638316953567,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609413343","repostId":"1190499118","repostType":4,"repost":{"id":"1190499118","kind":"news","pubTimestamp":1638315999,"share":"https://www.laohu8.com/m/news/1190499118?lang=&edition=full","pubTime":"2021-12-01 07:46","market":"us","language":"en","title":"HP Enterprise Forecast Falls Short on Chip Supply Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=1190499118","media":"Bloomberg","summary":"Hewlett Packard Enterprise Co. gave a lackluster quarterly profit forecast, held back by shortages o","content":"<p>Hewlett Packard Enterprise Co. gave a lackluster quarterly profit forecast, held back by shortages of components that made it difficult to meet demand for its computer equipment. Shares slid in late trading.</p>\n<p>Profit, excluding certain items, will be 42 cents to 50 cents a share in the three months ending in January, the Houston-based company said Tuesday in a statement. That compares with analysts’ average projection of 49 cents, according to data compiled by Bloomberg.</p>\n<p>“Supply continued to be a problem and it will be in the short term,” Chief Executive Officer Antonio Neri said in an interview. “Demand significantly accelerated in the fourth quarter.”</p>\n<p>Like many of its peers in the computer industry, HPE is trying to lessen its reliance on hardware sales by persuading customers to pay for subscriptions to add-on services, which provide a steadier revenue stream. In the near term, its fortunes are still dependent on those one-time purchases. The company’s ability to fill orders has been constrained by global parts shortages, especially semiconductors. Competition for limited supply has forced up prices, squeezing profit.</p>\n<p>Shares fell as low as $12.88 in extended trading following the report, after closing at $14.35 in New York. The stock has jumped 21% this year.</p>\n<p>Neri maintained that demand remains robust, boosted by the broader return to offices and in-person study following the Covid-19 lockdowns, and the embrace of new technology those shifts in the economy have created.</p>\n<p>Orders for the fiscal year that ended Oct. 31 were up 16% from the prior year, HPE said in the statement. Neri dismissed concerns that customers might be double ordering in an attempt to make sure they get most of what they need -- something that would pump up orders beyond real demand.</p>\n<p>In the fourth quarter, revenue rose 2% to $7.35 billion. Profit, excluding some items, was 52 cents a share. Analysts, on average, estimated adjusted earnings of 48 cents a share on revenue of $7.38 billion.</p>\n<p>Sales at HPE’s biggest unit, Compute, rose 1.1% to $3.2 billion. Storage revenue gained 3.5% to $1.26 billion. The Intelligent Edge unit, which sells devices used to link and manage previously unconnected gear, gained 3.7% to $815 million.</p>\n<p></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HP Enterprise Forecast Falls Short on Chip Supply Struggles</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHP Enterprise Forecast Falls Short on Chip Supply Struggles\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 07:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/hp-enterprise-forecast-falls-short-213857086.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hewlett Packard Enterprise Co. gave a lackluster quarterly profit forecast, held back by shortages of components that made it difficult to meet demand for its computer equipment. Shares slid in late ...</p>\n\n<a href=\"https://finance.yahoo.com/news/hp-enterprise-forecast-falls-short-213857086.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HPE":"慧与科技"},"source_url":"https://finance.yahoo.com/news/hp-enterprise-forecast-falls-short-213857086.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190499118","content_text":"Hewlett Packard Enterprise Co. gave a lackluster quarterly profit forecast, held back by shortages of components that made it difficult to meet demand for its computer equipment. Shares slid in late trading.\nProfit, excluding certain items, will be 42 cents to 50 cents a share in the three months ending in January, the Houston-based company said Tuesday in a statement. That compares with analysts’ average projection of 49 cents, according to data compiled by Bloomberg.\n“Supply continued to be a problem and it will be in the short term,” Chief Executive Officer Antonio Neri said in an interview. “Demand significantly accelerated in the fourth quarter.”\nLike many of its peers in the computer industry, HPE is trying to lessen its reliance on hardware sales by persuading customers to pay for subscriptions to add-on services, which provide a steadier revenue stream. In the near term, its fortunes are still dependent on those one-time purchases. The company’s ability to fill orders has been constrained by global parts shortages, especially semiconductors. Competition for limited supply has forced up prices, squeezing profit.\nShares fell as low as $12.88 in extended trading following the report, after closing at $14.35 in New York. The stock has jumped 21% this year.\nNeri maintained that demand remains robust, boosted by the broader return to offices and in-person study following the Covid-19 lockdowns, and the embrace of new technology those shifts in the economy have created.\nOrders for the fiscal year that ended Oct. 31 were up 16% from the prior year, HPE said in the statement. Neri dismissed concerns that customers might be double ordering in an attempt to make sure they get most of what they need -- something that would pump up orders beyond real demand.\nIn the fourth quarter, revenue rose 2% to $7.35 billion. Profit, excluding some items, was 52 cents a share. Analysts, on average, estimated adjusted earnings of 48 cents a share on revenue of $7.38 billion.\nSales at HPE’s biggest unit, Compute, rose 1.1% to $3.2 billion. Storage revenue gained 3.5% to $1.26 billion. The Intelligent Edge unit, which sells devices used to link and manage previously unconnected gear, gained 3.7% to $815 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600693409,"gmtCreate":1638144714825,"gmtModify":1638144714910,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600693409","repostId":"1119413089","repostType":4,"repost":{"id":"1119413089","kind":"news","pubTimestamp":1638143409,"share":"https://www.laohu8.com/m/news/1119413089?lang=&edition=full","pubTime":"2021-11-29 07:50","market":"sg","language":"en","title":"Airlines Scramble to Navigate Fast-Degrading Travel Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1119413089","media":"Bloomberg","summary":"Airlines, passengers and businesses scrambled to respond to a deluge of travel restrictions announce","content":"<p>Airlines, passengers and businesses scrambled to respond to a deluge of travel restrictions announced over the weekend to slow the spread of the omicron coronavirus variant.</p>\n<p>An initial spate of flight bans from southern Africa, where omicron was first detected, gave way to more wide-ranging measures that will make travel more expensive and less convenient -- if possible at all -- recalling earlier days in the pandemic.</p>\n<p>The U.K. re-introduced mandatory PCR tests for all arriving passengers and said they must self-isolate until receiving a negative result. Israel closed to all inbound foreign nationals for 14 days, while the Philippines said travelers from European countries including Switzerland and the Netherlands won’t be welcome for several weeks.</p>\n<p>Spain and Switzerland tightened access for arrivals from Britain, whose travel comeback has quickly been thrown into reverse. U.K. low-cost carrier&nbsp;EasyJet Plcsaid Sunday its flight schedule was operating as normal, “however we continue to monitor the situation closely.”</p>\n<p>While the full impact will get clearer over coming days, “this will be problematic for business travel -- particularly inbound into the U.K.,” said Martin Ferguson, a spokesman for American Express Global Business Travel.</p>\n<p>Travel Dilemma</p>\n<p>Organizers of the World Aviation Festival in London told attendees the event will go on as scheduled starting Tuesday, the day the new U.K. rules come into effect. The group arranged for testing at two nearby hotels where delegates who are guests can self-isolate while awaiting results.</p>\n<p>A separate, internal corporate event in the U.K. was shifted to hybrid from in-person, because the new testing and isolation requirements would have caught out some attendees set to arrive on Tuesday, according to a person familiar with the matter.</p>\n<p>Negative Incentives</p>\n<p>Leisure travel will also see an impact, while friends and relatives visiting loved ones after long absences are more likely to go through with a trip, said Alex Irving, an analyst at Bernstein in London.</p>\n<p>“Christmas bookings will obviously be weaker than we had expected prior to the omicron variant,” he said. “As you add barriers to travel such as the PCR tests and isolation requirements, all that does is changes the incentives.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/95c3ac1bcabb2d4fb1b1ed294198a405\" tg-width=\"1000\" tg-height=\"666\" width=\"100%\" height=\"auto\"><span>A covid testing centre sign at Heathrow Terminal 2 on Nov. 28.Photographer: Hollie Adams/Getty ImagesStep Backward</span></p>\n<p>Airlines now face a return to the uncertainty of shifting rules and public-health developments that threw customer plans into chaos and undermined demand earlier in the pandemic.</p>\n<p>British Airways, for example,&nbsp;halted flights&nbsp;to Hong Kong through at least Nov. 30 after one employee tested positive for Covid-19 and staff were sent into quarantine. The airline said it’s keeping its operations under review as the situation evolves.</p>\n<p>Singapore and Japan are among countries that have said they’re considering tighter border restrictions.</p>\n<p>The risk of a second lost winter has already tanked shares of airline stocks, with the Bloomberg EMEA Airline Index down 18% this month. This will make it harder to raise fresh capital to repair balance sheets -- British Airways parentI&nbsp;AG SA&nbsp;has 12.4 billion euros ($14 billion) in net debt, for example.</p>\n<p>“This comes at a time of year when airlines will seek to bolster liquidity and to a modest extent profitability, and is after an already arduous 18 months of revenue depletion,” said John Strickland, who heads London-based JLS Consulting.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Airlines Scramble to Navigate Fast-Degrading Travel Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAirlines Scramble to Navigate Fast-Degrading Travel Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 07:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-28/airlines-scramble-to-navigate-fast-degrading-travel-outlook><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Airlines, passengers and businesses scrambled to respond to a deluge of travel restrictions announced over the weekend to slow the spread of the omicron coronavirus variant.\nAn initial spate of flight...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-28/airlines-scramble-to-navigate-fast-degrading-travel-outlook\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAL":"美国航空","UAL":"联合大陆航空","LUV":"西南航空","DAL":"达美航空"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-28/airlines-scramble-to-navigate-fast-degrading-travel-outlook","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119413089","content_text":"Airlines, passengers and businesses scrambled to respond to a deluge of travel restrictions announced over the weekend to slow the spread of the omicron coronavirus variant.\nAn initial spate of flight bans from southern Africa, where omicron was first detected, gave way to more wide-ranging measures that will make travel more expensive and less convenient -- if possible at all -- recalling earlier days in the pandemic.\nThe U.K. re-introduced mandatory PCR tests for all arriving passengers and said they must self-isolate until receiving a negative result. Israel closed to all inbound foreign nationals for 14 days, while the Philippines said travelers from European countries including Switzerland and the Netherlands won’t be welcome for several weeks.\nSpain and Switzerland tightened access for arrivals from Britain, whose travel comeback has quickly been thrown into reverse. U.K. low-cost carrier EasyJet Plcsaid Sunday its flight schedule was operating as normal, “however we continue to monitor the situation closely.”\nWhile the full impact will get clearer over coming days, “this will be problematic for business travel -- particularly inbound into the U.K.,” said Martin Ferguson, a spokesman for American Express Global Business Travel.\nTravel Dilemma\nOrganizers of the World Aviation Festival in London told attendees the event will go on as scheduled starting Tuesday, the day the new U.K. rules come into effect. The group arranged for testing at two nearby hotels where delegates who are guests can self-isolate while awaiting results.\nA separate, internal corporate event in the U.K. was shifted to hybrid from in-person, because the new testing and isolation requirements would have caught out some attendees set to arrive on Tuesday, according to a person familiar with the matter.\nNegative Incentives\nLeisure travel will also see an impact, while friends and relatives visiting loved ones after long absences are more likely to go through with a trip, said Alex Irving, an analyst at Bernstein in London.\n“Christmas bookings will obviously be weaker than we had expected prior to the omicron variant,” he said. “As you add barriers to travel such as the PCR tests and isolation requirements, all that does is changes the incentives.\nA covid testing centre sign at Heathrow Terminal 2 on Nov. 28.Photographer: Hollie Adams/Getty ImagesStep Backward\nAirlines now face a return to the uncertainty of shifting rules and public-health developments that threw customer plans into chaos and undermined demand earlier in the pandemic.\nBritish Airways, for example, halted flights to Hong Kong through at least Nov. 30 after one employee tested positive for Covid-19 and staff were sent into quarantine. The airline said it’s keeping its operations under review as the situation evolves.\nSingapore and Japan are among countries that have said they’re considering tighter border restrictions.\nThe risk of a second lost winter has already tanked shares of airline stocks, with the Bloomberg EMEA Airline Index down 18% this month. This will make it harder to raise fresh capital to repair balance sheets -- British Airways parentI AG SA has 12.4 billion euros ($14 billion) in net debt, for example.\n“This comes at a time of year when airlines will seek to bolster liquidity and to a modest extent profitability, and is after an already arduous 18 months of revenue depletion,” said John Strickland, who heads London-based JLS Consulting.","news_type":1},"isVote":1,"tweetType":1,"viewCount":148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600388344,"gmtCreate":1638067713162,"gmtModify":1638067713283,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600388344","repostId":"2186340224","repostType":4,"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877723228,"gmtCreate":1637986937067,"gmtModify":1637986937130,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3561459567222461","idStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877723228","repostId":"1138332509","repostType":4,"repost":{"id":"1138332509","kind":"news","pubTimestamp":1637978067,"share":"https://www.laohu8.com/m/news/1138332509?lang=&edition=full","pubTime":"2021-11-27 09:54","market":"us","language":"en","title":"Did Qualcomm Just Reveal One of Meta's Biggest Secrets?","url":"https://stock-news.laohu8.com/highlight/detail?id=1138332509","media":"Motley Fool","summary":"Meta Platforms, the tech giant formerly known as Facebook, has never revealed any exact shipment figures for its Oculus virtual reality  headsets. But it's dropped plenty of hints along the way.Two years ago, CEO Mark Zuckerberg set a long-term goal of hitting 10 million VR users to become a sustainable software platform for developers. This August, Meta's AR and VR chief Andrew Bosworth said he was \"convinced\" it would hit that threshold earlier than it \"had initially expected.\". In a subsequen","content":"<p><b>Meta Platforms</b>(NASDAQ:FB), the tech giant formerly known as Facebook, has never revealed any exact shipment figures for its Oculus virtual reality (VR) headsets. But it's dropped plenty of hints along the way.</p>\n<p>Two years ago, CEO Mark Zuckerberg set a long-term goal of hitting 10 million VR users to become a sustainable software platform for developers. This August, Meta's AR and VR chief Andrew Bosworth said he was \"convinced\" it would hit that threshold earlier than it \"had initially expected.\"</p>\n<p>Meta didn't say anything else about hitting that target during last quarter's&nbsp;conference call, but it attributed the 195% year-over-year growth of its \"others\" segment to \"strong Quest 2 sales.\" However,<b>Qualcomm</b>(NASDAQ:QCOM)&nbsp;seemingly let the cat of the bag in a recent investor day presentation, when CEO Cristiano Amon casually noted that Oculus had shipped 10 million Quest 2 headsets since its launch last October.</p>\n<p>In a subsequent statement, Qualcomm said that figure was actually based on third-party estimates and wasn't \"meant as an official disclosure of sales numbers by Meta or Qualcomm.\" But even if those numbers weren't official, they give investors a much clearer view of Meta's opaque Oculus segment.</p>\n<p>Why does Meta want to sell 10 million headsets?</p>\n<p>Meta bought Oculus VR in 2014, and it launched its first commercial headset, the Oculus Rift, in 2016. However, the Rift remained a niche gaming device that needed to be tethered to a high-end PC.</p>\n<p>To address those limitations, Meta launched its first wireless VR headset, the Oculus Go, in 2018. It wasn't as powerful as the Rift, but it didn't need to be tethered to a PC or mobile device. It followed up the Go with the more powerful Oculus Quest in 2019, and it launched the Quest 2 -- which was even more powerful, lighter, and had better controllers -- last year.</p>\n<p>The success of the Quest headsets enabled Meta to sell more&nbsp;VR games&nbsp;and experiences on the platform. Last May, it said the Quest platform had surpassed $100 million in VR content sales. This January, it said that over 60 Oculus Quest titles had surpassed $1 million in revenue. This October, it said&nbsp;<i>Beat Saber</i>-- the hit VR rhythm game it acquired in late 2019 -- had exceeded $100 million in lifetime sales on the Quest platform alone.</p>\n<p>Those sales figures are tiny compared to Meta's estimated revenue of $117.8 billion this year. Ten million headsets might also sound paltry compared to other gaming platforms.<b>Nintendo</b>, for example, has shipped nearly 95 million Switch devices since 2017.</p>\n<p>However, the Quest has still set up the foundations for Meta's push into the \"metaverse\" -- which already includes new augmented reality (AR) devices like its new Ray-Ban smartglasses and Horizon Workrooms, which enable remote workers to hold VR meetings with digital avatars. The expansion of that ecosystem could gradually tie together its social networking, AR, and VR platforms, while significantly extending its reach beyond PCs and mobile devices.</p>\n<p>Why is Qualcomm talking about VR headsets?</p>\n<p>Qualcomm's chipsets power the Oculus Go, Quest, and Quest 2 headsets. The Go and first-generation Quest both used Snapdragon mobile system on chips (SoCs), which were commonly used in mobile phones.</p>\n<p>However, the second-generation Quest used the new Snapdragon XR2 SoC, which was specifically designed with VR and AR devices in mind. The chipset can be tethered to seven concurrent cameras to track a user's motions and gestures, supports 8K 360-degree videos, provides 3D audio, and supports AI processing features for voice commands.</p>\n<p>Qualcomm is selling more VR/AR chips to diversify its core business away from the smartphone market. That market is heavily commoditized, and it's facing intense competition from rivals like&nbsp;<b>MediaTek</b>&nbsp;as well as first-party chipsets from original equipment manufacturers (OEMs) like&nbsp;<b>Apple</b>,<b>Samsung</b>, and&nbsp;<b>Huawei</b>.</p>\n<p>That's also why Qualcomm has been rolling out new specialized chipsets for wearables, cars, drones, and other Internet of Things (IoT) devices in recent years. None of these chipsets are significantly reducing its dependence on the smartphone market yet, but that could change over the next few years.</p>\n<p>For example, the global AR and VR market could grow at a compound annual growth rate (CAGR) of 46% between 2021 and 2025, according to Technavio. But the global smartphone market might only grow at a CAGR of 1.7% between 2021 and 2026, according to Mordor Intelligence.</p>\n<p>We should take those estimates with a grain of salt, but it's easy to see why Qualcomm is so keen to develop new VR chips for Meta. If VR headset sales tale off over the next few years, Qualcomm could dominate that platform with its chips in the same way it became the market leader in smartphone chips.</p>\n<p>Setting up the foundations of the future</p>\n<p>Qualcomm's revelation, official or not, indicates Meta's VR business is growing rapidly. It isn't as large as the top gaming consoles yet, but it's gaining momentum and forming the foundations of its metaverse business.</p>\n<p>Investors shouldn't expect Meta and Qualcomm to generate significant revenue from those efforts in the near future. But over the long term, they could significantly transform the business models of both companies.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Did Qualcomm Just Reveal One of Meta's Biggest Secrets?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDid Qualcomm Just Reveal One of Meta's Biggest Secrets?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-27 09:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/26/did-qualcomm-just-reveal-meta-biggest-secret/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meta Platforms(NASDAQ:FB), the tech giant formerly known as Facebook, has never revealed any exact shipment figures for its Oculus virtual reality (VR) headsets. But it's dropped plenty of hints along...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/26/did-qualcomm-just-reveal-meta-biggest-secret/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/11/26/did-qualcomm-just-reveal-meta-biggest-secret/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138332509","content_text":"Meta Platforms(NASDAQ:FB), the tech giant formerly known as Facebook, has never revealed any exact shipment figures for its Oculus virtual reality (VR) headsets. But it's dropped plenty of hints along the way.\nTwo years ago, CEO Mark Zuckerberg set a long-term goal of hitting 10 million VR users to become a sustainable software platform for developers. This August, Meta's AR and VR chief Andrew Bosworth said he was \"convinced\" it would hit that threshold earlier than it \"had initially expected.\"\nMeta didn't say anything else about hitting that target during last quarter's conference call, but it attributed the 195% year-over-year growth of its \"others\" segment to \"strong Quest 2 sales.\" However,Qualcomm(NASDAQ:QCOM) seemingly let the cat of the bag in a recent investor day presentation, when CEO Cristiano Amon casually noted that Oculus had shipped 10 million Quest 2 headsets since its launch last October.\nIn a subsequent statement, Qualcomm said that figure was actually based on third-party estimates and wasn't \"meant as an official disclosure of sales numbers by Meta or Qualcomm.\" But even if those numbers weren't official, they give investors a much clearer view of Meta's opaque Oculus segment.\nWhy does Meta want to sell 10 million headsets?\nMeta bought Oculus VR in 2014, and it launched its first commercial headset, the Oculus Rift, in 2016. However, the Rift remained a niche gaming device that needed to be tethered to a high-end PC.\nTo address those limitations, Meta launched its first wireless VR headset, the Oculus Go, in 2018. It wasn't as powerful as the Rift, but it didn't need to be tethered to a PC or mobile device. It followed up the Go with the more powerful Oculus Quest in 2019, and it launched the Quest 2 -- which was even more powerful, lighter, and had better controllers -- last year.\nThe success of the Quest headsets enabled Meta to sell more VR games and experiences on the platform. Last May, it said the Quest platform had surpassed $100 million in VR content sales. This January, it said that over 60 Oculus Quest titles had surpassed $1 million in revenue. This October, it said Beat Saber-- the hit VR rhythm game it acquired in late 2019 -- had exceeded $100 million in lifetime sales on the Quest platform alone.\nThose sales figures are tiny compared to Meta's estimated revenue of $117.8 billion this year. Ten million headsets might also sound paltry compared to other gaming platforms.Nintendo, for example, has shipped nearly 95 million Switch devices since 2017.\nHowever, the Quest has still set up the foundations for Meta's push into the \"metaverse\" -- which already includes new augmented reality (AR) devices like its new Ray-Ban smartglasses and Horizon Workrooms, which enable remote workers to hold VR meetings with digital avatars. The expansion of that ecosystem could gradually tie together its social networking, AR, and VR platforms, while significantly extending its reach beyond PCs and mobile devices.\nWhy is Qualcomm talking about VR headsets?\nQualcomm's chipsets power the Oculus Go, Quest, and Quest 2 headsets. The Go and first-generation Quest both used Snapdragon mobile system on chips (SoCs), which were commonly used in mobile phones.\nHowever, the second-generation Quest used the new Snapdragon XR2 SoC, which was specifically designed with VR and AR devices in mind. The chipset can be tethered to seven concurrent cameras to track a user's motions and gestures, supports 8K 360-degree videos, provides 3D audio, and supports AI processing features for voice commands.\nQualcomm is selling more VR/AR chips to diversify its core business away from the smartphone market. That market is heavily commoditized, and it's facing intense competition from rivals like MediaTek as well as first-party chipsets from original equipment manufacturers (OEMs) like Apple,Samsung, and Huawei.\nThat's also why Qualcomm has been rolling out new specialized chipsets for wearables, cars, drones, and other Internet of Things (IoT) devices in recent years. None of these chipsets are significantly reducing its dependence on the smartphone market yet, but that could change over the next few years.\nFor example, the global AR and VR market could grow at a compound annual growth rate (CAGR) of 46% between 2021 and 2025, according to Technavio. But the global smartphone market might only grow at a CAGR of 1.7% between 2021 and 2026, according to Mordor Intelligence.\nWe should take those estimates with a grain of salt, but it's easy to see why Qualcomm is so keen to develop new VR chips for Meta. If VR headset sales tale off over the next few years, Qualcomm could dominate that platform with its chips in the same way it became the market leader in smartphone chips.\nSetting up the foundations of the future\nQualcomm's revelation, official or not, indicates Meta's VR business is growing rapidly. It isn't as large as the top gaming consoles yet, but it's gaining momentum and forming the foundations of its metaverse business.\nInvestors shouldn't expect Meta and Qualcomm to generate significant revenue from those efforts in the near future. But over the long term, they could significantly transform the business models of both companies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":832694341,"gmtCreate":1629615851183,"gmtModify":1633683725094,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/832694341","repostId":"1133515985","repostType":4,"isVote":1,"tweetType":1,"viewCount":64,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":873061896,"gmtCreate":1636802131946,"gmtModify":1636802132002,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/873061896","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":152,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840959471,"gmtCreate":1635578099920,"gmtModify":1635578099920,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/840959471","repostId":"1112945208","repostType":4,"repost":{"id":"1112945208","kind":"news","pubTimestamp":1635577312,"share":"https://www.laohu8.com/m/news/1112945208?lang=&edition=full","pubTime":"2021-10-30 15:01","market":"hk","language":"en","title":"Wall Street Crime and Punishment: Christian Meissenn And His Penny Stock Pump-And-Dump Games","url":"https://stock-news.laohu8.com/highlight/detail?id=1112945208","media":"Benzinga","summary":"Does crime pay?\nWall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicl","content":"<p><i>Does crime pay?</i></p>\n<p><i>Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition and greed take them in the wrong direction.</i></p>\n<p>“Be careful who you let into your life,” declared a meme on<b>Christian Meissenn’s</b>Instagram page. “People will come and drain the s**t out of you…then leave and blame everything on you.”</p>\n<p>Was Meissenn’s meme a cry of anguished warning against a world full of evil, or a self-tribute? After all, his claim to notoriety was ruining the lives of thousands of people who saw their money disappear into his warped fantasy world of promised penny stock glories.</p>\n<p>The irony of that meme posting was that it happened at all. Meissen was able to play around on social media by making himself a victim of a greater injustice than the brutal scams he enacted on others.</p>\n<p>The Strategy: On Nov. 8, 2016, Meissenn pleaded guilty to <a href=\"https://laohu8.com/S/AONE.U\">one</a> count of conspiracy to commit mail and wire fraud and one count of tax evasion in connection to his grand scheme. A plea of not guilty would have been ridiculous — not with the wealth of evidence stacked against him.</p>\n<p>Starting in 2009, Meissenn and six accomplices (including two unscrupulous lawyers) orchestrated a seven-year pump-and-dump attack against vulnerable investors to buy shares in penny stock companies, which were mostly shell companies that fell under their control.</p>\n<p>This gang unleashed an endless series of telephone calls and emails that bombarded the investors with grand promises of extraordinary returns on investments, while dishonest press releases went across the Internet with wild misrepresentations of the companies’ activities. The attorneys signed phony opinion letters offering false assurances to securities transfer agents and prospective investors that they reviewed corporate records and filings for the issuing companies and were satisfied with the adequacy of the companies’ public disclosures.</p>\n<p>Meissenn and his gang gleefully reeled-in victims who naively sank money into the worthless stocks, bringing their prices to heights where they never belonged. When the prices reached inflated zeniths, the miscreants quickly cashed out and laughed over their gains while their investors were left with worthless stocks and no hope of recovering their losses. By the time the feds moved in during the summer of 2016, more than 12,000 investors collectively lost nearly $19 million.</p>\n<p>Between 2011 and 2015, Meissenn accumulated roughly approximately $4.4 million from the scheme, but rather than deposit the money into his bank account he diverted most of his ill-gotten gains into an attorney’s trust account. The attorney was then directed to either wire funds or send checks to Meissenn — and none of this money was declared on his income taxes. When the Internal Revenue Service finally figured out what he pulled, Meissenn had tiptoed away from paying $1.5 million in federal income taxes.</p>\n<p>A declaration of innocence in the face of this evidence was untenable, Meissenn realized, but cooperating with guilty pleas was not a happier solution. He faced up to 20 years behind bars for accepting guilt on the conspiracy to commit mail and wire fraud charge and a maximum of five years for the tax evasion count.</p>\n<p>But Meissenn had a curious talent for hitting a cosmic reset button that changed his situation when change was needed.</p>\n<p>The American Adventure: Christian Meissenn only existed in America — in his native Bulgaria, he was Christian Levon Nigohossian. In 1987, the 15-year-old Nigohossian and his mother fled their impoverished country and a miserable domestic life under his abusive father for a better opportunity across the Atlantic.</p>\n<p>He would later claim that his mother worked very long hours to support them, which distorted their relationship — he recalled their relationship was “more a friendship than a parental one.”</p>\n<p>He may or may not have fallen into juvenile delinquency. An unpublished autobiographical novel called “Raised by Wolves” offers a colorful, Martin Scorsese-style coming-of-age tale with street gangs and petty crime, but given his shaky acquaintance with the truth it is hard to discern where boisterous tales replaces less-than-entertaining facts. Still, another meme on his Instagram page asked male viewers to “Be the Man You Needed as a Boy,” a hint that his youthful years went awry without paternal guidance.</p>\n<p>Nigohossian found his way into the broker-dealer world in the mid-1990s and began to claim executive positions in sketchy companies. He was cited as treasurer and secretary of The Minneapolis Company and president of Speed of Thought Trading Corp. and GIT Securities. Most of these companies were expelled from their industry by FINRA, which also barred Nigohossian from working as a broker.</p>\n<p>Somewhere along the way, Nigohossian jettisoned his surname for Meissenn. He would call himself Christian Mason and Christopher Mason in his penny stock scheme and he erased all traces of his Eastern European roots from his voice, speaking English with a non-regional American accent. He also found his way to Connecticut, where he registered a skein of intriguing business names with the state, including Bubble’s Lounge and Pip Stop Trading without actually setting up a business.</p>\n<p>In September 2013, the Connecticut Department of Banking issued a cease-and-desist order after determining Meissenn and his business cronies sold unregistered securities for six companies in violation of state law. He was also accused of violating state law by “inducing investors who previously bought securities issued by one or more of the referenced entities to swap their shares at a premium for different securities, promising profitability but not disclosing critical information on the entity, the involvement of Meissenn in the entity’s operations and the impact of dilution.”</p>\n<p>Despite these setbacks, Meissen carried on and in 2017 he claimed to hold the rights to the Atari Games trademark and was “rebuilding the brand in a brand new entity.” This claim came as a surprise to Atari Interactive, which filed a complaint with the U.S. Patent and Trademark Office. Incredibly, this occurred while Meissenn was awaiting sentencing for his penny stock swindles.</p>\n<p>The Ultimate Death Sentence: Meissenn was free on bail after pleading guilty to his penny stock chicanery, but his original sentencing date of Jan. 31, 2017, wound up being postponed until Nov. 30, 2018, due to the aggressive work of his attorney, Cody N. Guarnieri, in turning Meissenn from a predator into a victim.</p>\n<p>Guarnieri disclosed during the sentencing that Meissenn was a patient at Yale New Haven Hospital for two rare diseases: Erdheim-Chester disease, a slow-metastasizing blood cancer, and retroperitoneal fibrosis, an inflammatory disorder that creates abnormal fiber-like tissue in the abdomen. Guarnieri informed the court that Meissenn’s condition was terminal and the chemotherapy treatment he was receiving would only slow the diseases but not cure him.</p>\n<p>Even worse, Guarnieri argued, was whether Meissenn could receive proper medical care while in prison — without the proper care, the attorney insisted, Meissenn would be assured that his prison term would be a death sentence.</p>\n<p>Amazingly, Guarnieri was able to recruit prosecutors to his side, with Assistant U.S. Attorney Avi M. Perry informing the court that Meissenn only had between 1½ and 5 years to live.</p>\n<p>Meissenn’s wife Kerry was brought forth to close the sale, recounting the tragedy in watching her husband’s rapidly deteriorating health, including decreased mobility, fraying memory, and shaking and vomiting from the chemotherapy treatments.</p>\n<p>“He is definitely not the man I married,” she said, begging the court to allow her husband to serve his sentence under house arrest without prison time.</p>\n<p>U.S. District Court Judge Jeffrey A. Meyer listened to the presentations in his New Haven court and spoke calmly about the case before him. He did not absolve Meissenn, branding him as a “brazen criminal” who became wealthy by “ripping people off.” Meyer also pointed to the health issues that burdened the “staggering number of victims” of Meissenn’s pump and dump scam.</p>\n<p>And then, Meyer embraced the argument for leniency.</p>\n<p>“The victims come to court and say they want justice done and don’t even care about the how,” Meyer said. “I look at your case, and I have to wonder whether some providential force — I’m sure this has crossed your mind many times — has essentially decided to send you something much worse than this court could ever do.</p>\n<p>“I believe you should serve some prison time,” Meyer added, “but I don’t believe it should be so much you don’t see your children again.”</p>\n<p>Meyer sentenced Meissenn to three months in prison followed by three years of supervised release under house arrest in the comfort of his Suffield, Connecticut, residence. He also ordered Meissenn to pay restitution of $5.3 million to the victims and $1.5 million to the IRS for unpaid taxes, although he acknowledged it was unlikely Meissenn would ever be able to fulfill that requirement.</p>\n<p>Meissenn entered prison in January 2019 and was out in April 2019. In comparison, two of Meissenn’s collaborators each received prison terms of six years months while two others received seven-year sentences. The two attorneys involved in the scam each received three-year sentences.</p>\n<p>Denouement: While Meissenn apologized for his actions during his sentencing, his life outside of his brief stretch behind bars was remarkably free from remorse.</p>\n<p>Meissenn said he authored the autobiographical “Raised By Wolves” and offered graphic novel illustrative glimpses of his story on Instagram of its content. He also claimed a film version was in the works starring Danny Aiello, but there is no evidence that the Oscar-nominated actor was ever attached to this project. Aiello died in December 2019 and Meissenn ceased trumpeting a film production after he passed away.</p>\n<p>Meissenn started a website called Humor the Tumor to find a light spot in chemotherapy treatment but abandoned it after a few dismal attempts at levity. He filled his Instagram page with scatological angry memes and photographs of himself with his hair growing to flowing lengths — in one video post, he blamed chemotherapy for hair loss and then credited it for allowing his tresses to return with a vengeance.</p>\n<p>One Instagram image from September 2020 showed Meissenn’s hand on the steering wheel of his Lincoln Town Car. Meissenn was driving that vehicle on Aug. 16, 2021, when he was killed in a multiple-vehicle crash on I-95 in lower Connecticut. He was 49 years old at the time of his death and roughly 80 miles away from where he was supposed to have been under house arrest.</p>\n<p>In the month before his court sentencing, Meissenn posted a photograph of himself on Instagram lying on a pillow featuring the message “People are f**king scumbags” while holding up a book titled “How to Be Your Own Best Friend.” Perhaps this photo encapsulated everything that was wrong with Meissenn — the pillow’s contemptuous message was mirrored in the venality of his stock swindles, and the book he displayed offered cruel evidence that he stupidly self-identified as his own best friend when, in reality, he was really his own worst enemy.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street Crime and Punishment: Christian Meissenn And His Penny Stock Pump-And-Dump Games</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street Crime and Punishment: Christian Meissenn And His Penny Stock Pump-And-Dump Games\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-30 15:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/10/23699981/wall-street-crime-and-punishment-christian-meissenn-and-his-penny-stock-pump-and-dump-games><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Does crime pay?\nWall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition and greed take them in the ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/10/23699981/wall-street-crime-and-punishment-christian-meissenn-and-his-penny-stock-pump-and-dump-games\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/76a5f973ee63cb45a72044f57e3a023d","relate_stocks":{},"source_url":"https://www.benzinga.com/news/21/10/23699981/wall-street-crime-and-punishment-christian-meissenn-and-his-penny-stock-pump-and-dump-games","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112945208","content_text":"Does crime pay?\nWall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition and greed take them in the wrong direction.\n“Be careful who you let into your life,” declared a meme onChristian Meissenn’sInstagram page. “People will come and drain the s**t out of you…then leave and blame everything on you.”\nWas Meissenn’s meme a cry of anguished warning against a world full of evil, or a self-tribute? After all, his claim to notoriety was ruining the lives of thousands of people who saw their money disappear into his warped fantasy world of promised penny stock glories.\nThe irony of that meme posting was that it happened at all. Meissen was able to play around on social media by making himself a victim of a greater injustice than the brutal scams he enacted on others.\nThe Strategy: On Nov. 8, 2016, Meissenn pleaded guilty to one count of conspiracy to commit mail and wire fraud and one count of tax evasion in connection to his grand scheme. A plea of not guilty would have been ridiculous — not with the wealth of evidence stacked against him.\nStarting in 2009, Meissenn and six accomplices (including two unscrupulous lawyers) orchestrated a seven-year pump-and-dump attack against vulnerable investors to buy shares in penny stock companies, which were mostly shell companies that fell under their control.\nThis gang unleashed an endless series of telephone calls and emails that bombarded the investors with grand promises of extraordinary returns on investments, while dishonest press releases went across the Internet with wild misrepresentations of the companies’ activities. The attorneys signed phony opinion letters offering false assurances to securities transfer agents and prospective investors that they reviewed corporate records and filings for the issuing companies and were satisfied with the adequacy of the companies’ public disclosures.\nMeissenn and his gang gleefully reeled-in victims who naively sank money into the worthless stocks, bringing their prices to heights where they never belonged. When the prices reached inflated zeniths, the miscreants quickly cashed out and laughed over their gains while their investors were left with worthless stocks and no hope of recovering their losses. By the time the feds moved in during the summer of 2016, more than 12,000 investors collectively lost nearly $19 million.\nBetween 2011 and 2015, Meissenn accumulated roughly approximately $4.4 million from the scheme, but rather than deposit the money into his bank account he diverted most of his ill-gotten gains into an attorney’s trust account. The attorney was then directed to either wire funds or send checks to Meissenn — and none of this money was declared on his income taxes. When the Internal Revenue Service finally figured out what he pulled, Meissenn had tiptoed away from paying $1.5 million in federal income taxes.\nA declaration of innocence in the face of this evidence was untenable, Meissenn realized, but cooperating with guilty pleas was not a happier solution. He faced up to 20 years behind bars for accepting guilt on the conspiracy to commit mail and wire fraud charge and a maximum of five years for the tax evasion count.\nBut Meissenn had a curious talent for hitting a cosmic reset button that changed his situation when change was needed.\nThe American Adventure: Christian Meissenn only existed in America — in his native Bulgaria, he was Christian Levon Nigohossian. In 1987, the 15-year-old Nigohossian and his mother fled their impoverished country and a miserable domestic life under his abusive father for a better opportunity across the Atlantic.\nHe would later claim that his mother worked very long hours to support them, which distorted their relationship — he recalled their relationship was “more a friendship than a parental one.”\nHe may or may not have fallen into juvenile delinquency. An unpublished autobiographical novel called “Raised by Wolves” offers a colorful, Martin Scorsese-style coming-of-age tale with street gangs and petty crime, but given his shaky acquaintance with the truth it is hard to discern where boisterous tales replaces less-than-entertaining facts. Still, another meme on his Instagram page asked male viewers to “Be the Man You Needed as a Boy,” a hint that his youthful years went awry without paternal guidance.\nNigohossian found his way into the broker-dealer world in the mid-1990s and began to claim executive positions in sketchy companies. He was cited as treasurer and secretary of The Minneapolis Company and president of Speed of Thought Trading Corp. and GIT Securities. Most of these companies were expelled from their industry by FINRA, which also barred Nigohossian from working as a broker.\nSomewhere along the way, Nigohossian jettisoned his surname for Meissenn. He would call himself Christian Mason and Christopher Mason in his penny stock scheme and he erased all traces of his Eastern European roots from his voice, speaking English with a non-regional American accent. He also found his way to Connecticut, where he registered a skein of intriguing business names with the state, including Bubble’s Lounge and Pip Stop Trading without actually setting up a business.\nIn September 2013, the Connecticut Department of Banking issued a cease-and-desist order after determining Meissenn and his business cronies sold unregistered securities for six companies in violation of state law. He was also accused of violating state law by “inducing investors who previously bought securities issued by one or more of the referenced entities to swap their shares at a premium for different securities, promising profitability but not disclosing critical information on the entity, the involvement of Meissenn in the entity’s operations and the impact of dilution.”\nDespite these setbacks, Meissen carried on and in 2017 he claimed to hold the rights to the Atari Games trademark and was “rebuilding the brand in a brand new entity.” This claim came as a surprise to Atari Interactive, which filed a complaint with the U.S. Patent and Trademark Office. Incredibly, this occurred while Meissenn was awaiting sentencing for his penny stock swindles.\nThe Ultimate Death Sentence: Meissenn was free on bail after pleading guilty to his penny stock chicanery, but his original sentencing date of Jan. 31, 2017, wound up being postponed until Nov. 30, 2018, due to the aggressive work of his attorney, Cody N. Guarnieri, in turning Meissenn from a predator into a victim.\nGuarnieri disclosed during the sentencing that Meissenn was a patient at Yale New Haven Hospital for two rare diseases: Erdheim-Chester disease, a slow-metastasizing blood cancer, and retroperitoneal fibrosis, an inflammatory disorder that creates abnormal fiber-like tissue in the abdomen. Guarnieri informed the court that Meissenn’s condition was terminal and the chemotherapy treatment he was receiving would only slow the diseases but not cure him.\nEven worse, Guarnieri argued, was whether Meissenn could receive proper medical care while in prison — without the proper care, the attorney insisted, Meissenn would be assured that his prison term would be a death sentence.\nAmazingly, Guarnieri was able to recruit prosecutors to his side, with Assistant U.S. Attorney Avi M. Perry informing the court that Meissenn only had between 1½ and 5 years to live.\nMeissenn’s wife Kerry was brought forth to close the sale, recounting the tragedy in watching her husband’s rapidly deteriorating health, including decreased mobility, fraying memory, and shaking and vomiting from the chemotherapy treatments.\n“He is definitely not the man I married,” she said, begging the court to allow her husband to serve his sentence under house arrest without prison time.\nU.S. District Court Judge Jeffrey A. Meyer listened to the presentations in his New Haven court and spoke calmly about the case before him. He did not absolve Meissenn, branding him as a “brazen criminal” who became wealthy by “ripping people off.” Meyer also pointed to the health issues that burdened the “staggering number of victims” of Meissenn’s pump and dump scam.\nAnd then, Meyer embraced the argument for leniency.\n“The victims come to court and say they want justice done and don’t even care about the how,” Meyer said. “I look at your case, and I have to wonder whether some providential force — I’m sure this has crossed your mind many times — has essentially decided to send you something much worse than this court could ever do.\n“I believe you should serve some prison time,” Meyer added, “but I don’t believe it should be so much you don’t see your children again.”\nMeyer sentenced Meissenn to three months in prison followed by three years of supervised release under house arrest in the comfort of his Suffield, Connecticut, residence. He also ordered Meissenn to pay restitution of $5.3 million to the victims and $1.5 million to the IRS for unpaid taxes, although he acknowledged it was unlikely Meissenn would ever be able to fulfill that requirement.\nMeissenn entered prison in January 2019 and was out in April 2019. In comparison, two of Meissenn’s collaborators each received prison terms of six years months while two others received seven-year sentences. The two attorneys involved in the scam each received three-year sentences.\nDenouement: While Meissenn apologized for his actions during his sentencing, his life outside of his brief stretch behind bars was remarkably free from remorse.\nMeissenn said he authored the autobiographical “Raised By Wolves” and offered graphic novel illustrative glimpses of his story on Instagram of its content. He also claimed a film version was in the works starring Danny Aiello, but there is no evidence that the Oscar-nominated actor was ever attached to this project. Aiello died in December 2019 and Meissenn ceased trumpeting a film production after he passed away.\nMeissenn started a website called Humor the Tumor to find a light spot in chemotherapy treatment but abandoned it after a few dismal attempts at levity. He filled his Instagram page with scatological angry memes and photographs of himself with his hair growing to flowing lengths — in one video post, he blamed chemotherapy for hair loss and then credited it for allowing his tresses to return with a vengeance.\nOne Instagram image from September 2020 showed Meissenn’s hand on the steering wheel of his Lincoln Town Car. Meissenn was driving that vehicle on Aug. 16, 2021, when he was killed in a multiple-vehicle crash on I-95 in lower Connecticut. He was 49 years old at the time of his death and roughly 80 miles away from where he was supposed to have been under house arrest.\nIn the month before his court sentencing, Meissenn posted a photograph of himself on Instagram lying on a pillow featuring the message “People are f**king scumbags” while holding up a book titled “How to Be Your Own Best Friend.” Perhaps this photo encapsulated everything that was wrong with Meissenn — the pillow’s contemptuous message was mirrored in the venality of his stock swindles, and the book he displayed offered cruel evidence that he stupidly self-identified as his own best friend when, in reality, he was really his own worst enemy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850037581,"gmtCreate":1634533418131,"gmtModify":1634533418229,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/850037581","repostId":"1185155570","repostType":4,"repost":{"id":"1185155570","kind":"news","pubTimestamp":1634511079,"share":"https://www.laohu8.com/m/news/1185155570?lang=&edition=full","pubTime":"2021-10-18 06:51","market":"us","language":"en","title":"Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1185155570","media":"Barrons","summary":"Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. ","content":"<p>Seventy-two&nbsp;S&amp;P 500&nbsp;companies report earnings this week,&nbsp;as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights&nbsp;will include&nbsp;results from notable companies in telecom, consumer staples, energy, technology, health care, and the airline industry.</p>\n<p><img src=\"https://static.tigerbbs.com/685ba1e7f4763c12a3c0159fc2469ded\" tg-width=\"1878\" tg-height=\"2461\" width=\"100%\" height=\"auto\"></p>\n<p>Albertsons and&nbsp;State Street&nbsp;get the ball rolling on Monday.Procter &amp; Gamble,Halliburton,and&nbsp;Johnson &amp; Johnson&nbsp;are Tuesday morning’s highlights, followed by&nbsp;Netflix&nbsp;and&nbsp;United Airlines Holdings&nbsp;after the market closes.</p>\n<p>On Wednesday,Verizon Communications,IBM,and Tesla will get the most attention.AT&amp;T, American Airlines Group,Southwest Airlines,and&nbsp;Chipotle Mexican Grill&nbsp;report on Thursday, then&nbsp;American Express,Schlumberger,and&nbsp;Honeywell International&nbsp;close the week on Friday.</p>\n<p>Economic data highlights this week include the Conference Board’s Leading Economic Index for September on Thursday and&nbsp;IHS Markit’s&nbsp;Manufacturing and Services Purchasing Managers’ indexes for October on Friday. All are seen easing back from their prior months’ levels.</p>\n<p>Other releases this week include the Federal Reserve’s most recent Beige Book, describing economic conditions across the U.S., and a pair of September housing-market indicators: The Census Bureau reports new residential construction data on Tuesday and the National Association of Realtors reports existing-home sales on Thursday.</p>\n<p><b>Monday 10/18</b></p>\n<p><b>The Federal Reserve</b>&nbsp;releases industrial production data for September. Economists are looking for a 0.20% rise after a 0.4% increase in August. Capacity utilization is expected at 76.5% for September, roughly in line with August’s 76.4%.</p>\n<p>Albertsons, Philips, Steel Dynamics, and State Street are among companies releasing quarterly financial results.</p>\n<p><b>Tuesday 10/19</b></p>\n<p><b>The Census Bureau</b> reports new residential construction data for September. Economists forecast a seasonally adjusted annual rate of 1.623 million housing starts, compared with 1.615 million in August.</p>\n<p>Halliburton, Procter &amp; Gamble, Johnson &amp; Johnson, Synchrony, Travelers, Philip Morris International, Kansas City Southern, WD-40, Interactive Brokers Group, Netflix, ManpowerGroup, Dover, and Canadian National Railway are among companies hosting earnings conference calls.</p>\n<p><b>Wednesday 10/20</b></p>\n<p><b>The Federal Reserve</b> releases its beige book about current economic conditions across the central bank’s 12 districts.</p>\n<p>Abbott Laboratories, Biogen, NextEra Energy, ASML Holding, Nasdaq, Canadian Pacific Railway, Verizon Communications, CSX, Lam Research, Tesla, IBM, and Anthem discuss quarterly financial results.</p>\n<p><b>Thursday 10/21</b></p>\n<p><b>The National Association</b> of Realtors reports existing-home sales for September. Economists forecast a seasonally adjusted annual rate of 6.10 million homes sold, compared with 5.88 million homes in August.</p>\n<p>Dow, Freeport-McMoRan, Genuine Parts, Southwest Airlines, Valero Energy, Blackstone, Quest Diagnostics, Snap-on, Tractor Supply, Barclays, Danaher, AT&amp;T, Nucor, American Airlines Group, AutoNation, Valero Energy, SL Green Realty, Intel, Snap, Boston Beer, Mattel, and Chipotle Mexican Grill host earnings conference calls to discuss quarterly results.</p>\n<p><b>The Philadelphia Fed</b>&nbsp;diffusion index, a measure of overall manufacturing activity, is expected to fall to 24 in October from September’s 30.7 reading.</p>\n<p><b>The Conference Board</b>&nbsp;releases its Leading Economic Index for September. Expectations are for a 0.50% rise, after August’s 0.90% gain.</p>\n<p><b>Friday 10/22</b></p>\n<p><b>IHS Markit releases</b>&nbsp;the Manufacturing and Services Purchasing Managers’ indexes for October. Consensus estimate for the Manufacturing PMI is 60.3, while the Services PMI is expected to be 54.7, compared with 60.7 and 54.9, respectively, in September.</p>\n<p>Whirlpool, Honeywell, Cleveland-Cliffs, Celanese, HCA Healthcare, Schlumberger, Seagate Technology Holdings, VF Corp., and American Express host investor conference calls.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-18 06:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","TSLA":"特斯拉","T":"美国电话电报","LUV":"西南航空","NFLX":"奈飞","CMG":"墨式烧烤",".SPX":"S&P 500 Index",".DJI":"道琼斯","HAL":"哈里伯顿","UAL":"联合大陆航空","AXP":"美国运通",".IXIC":"NASDAQ Composite","AAL":"美国航空","IBM":"IBM","INTC":"英特尔"},"source_url":"https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185155570","content_text":"Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights will include results from notable companies in telecom, consumer staples, energy, technology, health care, and the airline industry.\n\nAlbertsons and State Street get the ball rolling on Monday.Procter & Gamble,Halliburton,and Johnson & Johnson are Tuesday morning’s highlights, followed by Netflix and United Airlines Holdings after the market closes.\nOn Wednesday,Verizon Communications,IBM,and Tesla will get the most attention.AT&T, American Airlines Group,Southwest Airlines,and Chipotle Mexican Grill report on Thursday, then American Express,Schlumberger,and Honeywell International close the week on Friday.\nEconomic data highlights this week include the Conference Board’s Leading Economic Index for September on Thursday and IHS Markit’s Manufacturing and Services Purchasing Managers’ indexes for October on Friday. All are seen easing back from their prior months’ levels.\nOther releases this week include the Federal Reserve’s most recent Beige Book, describing economic conditions across the U.S., and a pair of September housing-market indicators: The Census Bureau reports new residential construction data on Tuesday and the National Association of Realtors reports existing-home sales on Thursday.\nMonday 10/18\nThe Federal Reserve releases industrial production data for September. Economists are looking for a 0.20% rise after a 0.4% increase in August. Capacity utilization is expected at 76.5% for September, roughly in line with August’s 76.4%.\nAlbertsons, Philips, Steel Dynamics, and State Street are among companies releasing quarterly financial results.\nTuesday 10/19\nThe Census Bureau reports new residential construction data for September. Economists forecast a seasonally adjusted annual rate of 1.623 million housing starts, compared with 1.615 million in August.\nHalliburton, Procter & Gamble, Johnson & Johnson, Synchrony, Travelers, Philip Morris International, Kansas City Southern, WD-40, Interactive Brokers Group, Netflix, ManpowerGroup, Dover, and Canadian National Railway are among companies hosting earnings conference calls.\nWednesday 10/20\nThe Federal Reserve releases its beige book about current economic conditions across the central bank’s 12 districts.\nAbbott Laboratories, Biogen, NextEra Energy, ASML Holding, Nasdaq, Canadian Pacific Railway, Verizon Communications, CSX, Lam Research, Tesla, IBM, and Anthem discuss quarterly financial results.\nThursday 10/21\nThe National Association of Realtors reports existing-home sales for September. Economists forecast a seasonally adjusted annual rate of 6.10 million homes sold, compared with 5.88 million homes in August.\nDow, Freeport-McMoRan, Genuine Parts, Southwest Airlines, Valero Energy, Blackstone, Quest Diagnostics, Snap-on, Tractor Supply, Barclays, Danaher, AT&T, Nucor, American Airlines Group, AutoNation, Valero Energy, SL Green Realty, Intel, Snap, Boston Beer, Mattel, and Chipotle Mexican Grill host earnings conference calls to discuss quarterly results.\nThe Philadelphia Fed diffusion index, a measure of overall manufacturing activity, is expected to fall to 24 in October from September’s 30.7 reading.\nThe Conference Board releases its Leading Economic Index for September. Expectations are for a 0.50% rise, after August’s 0.90% gain.\nFriday 10/22\nIHS Markit releases the Manufacturing and Services Purchasing Managers’ indexes for October. Consensus estimate for the Manufacturing PMI is 60.3, while the Services PMI is expected to be 54.7, compared with 60.7 and 54.9, respectively, in September.\nWhirlpool, Honeywell, Cleveland-Cliffs, Celanese, HCA Healthcare, Schlumberger, Seagate Technology Holdings, VF Corp., and American Express host investor conference calls.","news_type":1},"isVote":1,"tweetType":1,"viewCount":161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":898365190,"gmtCreate":1628474372010,"gmtModify":1633746923467,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"👍🏼👍🏼👍🏼","listText":"👍🏼👍🏼👍🏼","text":"👍🏼👍🏼👍🏼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/898365190","repostId":"1161520384","repostType":4,"isVote":1,"tweetType":1,"viewCount":168,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807870371,"gmtCreate":1628032498593,"gmtModify":1633754318527,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"👍🏼👍🏼👍🏼","listText":"👍🏼👍🏼👍🏼","text":"👍🏼👍🏼👍🏼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/807870371","repostId":"2156312793","repostType":4,"isVote":1,"tweetType":1,"viewCount":49,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":842629477,"gmtCreate":1636171715337,"gmtModify":1636171715464,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/842629477","repostId":"1173813098","repostType":4,"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":899572012,"gmtCreate":1628208567336,"gmtModify":1633752655638,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"👍🏼👍🏼👍🏼","listText":"👍🏼👍🏼👍🏼","text":"👍🏼👍🏼👍🏼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/899572012","repostId":"2157456017","repostType":4,"repost":{"id":"2157456017","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1628204156,"share":"https://www.laohu8.com/m/news/2157456017?lang=&edition=full","pubTime":"2021-08-06 06:55","market":"us","language":"en","title":"Nasdaq, S&P 500, set records as jobless claims decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2157456017","media":"Reuters","summary":"* Nasdaq, S&P 500 close at record highs\n* Layoff at lowest in over 21 years\n* Healthcare and materia","content":"<p>* Nasdaq, S&amp;P 500 close at record highs</p>\n<p>* Layoff at lowest in over 21 years</p>\n<p>* Healthcare and materials sectoral losers on S&amp;P 500</p>\n<p>Aug 5 (Reuters) - The Nasdaq and S&amp;P 500 closed at record levels on Thursday after a spate of strong corporate earnings and a further decline in U.S. unemployment claims last week, as investors weighed concerns of the surge of the Delta variant ahead of Friday's job's report.</p>\n<p>Initial claims for state unemployment benefits fell by 14,000 to 385,000 in the week ended July 31, while layoffs dropped to their lowest level in more than 21 years last month as companies held on to their workers amid a labor shortage, the Labor Department's report showed.</p>\n<p>\"The directional change has continued to be improving in the last few weeks and now it's a new low since beginning the pandemic,\" said Keith Buchanan, portfolio manager at Globalt Investments in Atlanta, Georgia. \"I think that's what (is) kind of leading to some optimism today and earnings to this point have been positive.\"</p>\n<p>Nine of the 11 major S&amp;P 500 sector indexes rose, with healthcare stocks in the red as Cigna Corp slipped 10.9% after predicting a bigger hit to full-year earnings from the pandemic.</p>\n<p>Focus will now shift to the jobs report for July on Friday. Analysts say a disappointing number might raise questions about an economic recovery, but it could also lead the Federal Reserve to remain accommodative.</p>\n<p>Meanwhile, Robinhood Markets Inc tumbled 27.6%, snapping a four-day rally fueled by interest from retail traders.</p>\n<p>ViacomCBS Inc jumped 7.1% as the company said it signed up the highest number of new streaming subscribers in the second quarter, and struck a multi-year deal with Comcast Corp's&nbsp;Sky to launch the Paramount+ streaming service in Europe.</p>\n<p>The Dow Jones Industrial Average rose 271.58 points, or 0.78%, to 35,064.25, the S&amp;P 500 gained 26.44 points, or 0.60%, to 4,429.1 and the Nasdaq Composite added 114.58 points, or 0.78%, to 14,895.12.</p>\n<p>Concerns about the pace of economic growth and higher inflation have pressured the S&amp;P 500 index, but stellar corporate earnings so far have put it on track to end the week higher.</p>\n<p>Fed Vice Chair Richard Clarida, a major architect of the central bank's new policy strategy, said on Wednesday he felt the conditions for raising interest rates could be met by the end of 2022.</p>\n<p>Volume on U.S. exchanges was 8.86 billion shares, compared with the 9.63 billion average for the full session over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.26-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 111 new highs and 103 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq, S&P 500, set records as jobless claims decline</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq, S&P 500, set records as jobless claims decline\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-06 06:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Nasdaq, S&amp;P 500 close at record highs</p>\n<p>* Layoff at lowest in over 21 years</p>\n<p>* Healthcare and materials sectoral losers on S&amp;P 500</p>\n<p>Aug 5 (Reuters) - The Nasdaq and S&amp;P 500 closed at record levels on Thursday after a spate of strong corporate earnings and a further decline in U.S. unemployment claims last week, as investors weighed concerns of the surge of the Delta variant ahead of Friday's job's report.</p>\n<p>Initial claims for state unemployment benefits fell by 14,000 to 385,000 in the week ended July 31, while layoffs dropped to their lowest level in more than 21 years last month as companies held on to their workers amid a labor shortage, the Labor Department's report showed.</p>\n<p>\"The directional change has continued to be improving in the last few weeks and now it's a new low since beginning the pandemic,\" said Keith Buchanan, portfolio manager at Globalt Investments in Atlanta, Georgia. \"I think that's what (is) kind of leading to some optimism today and earnings to this point have been positive.\"</p>\n<p>Nine of the 11 major S&amp;P 500 sector indexes rose, with healthcare stocks in the red as Cigna Corp slipped 10.9% after predicting a bigger hit to full-year earnings from the pandemic.</p>\n<p>Focus will now shift to the jobs report for July on Friday. Analysts say a disappointing number might raise questions about an economic recovery, but it could also lead the Federal Reserve to remain accommodative.</p>\n<p>Meanwhile, Robinhood Markets Inc tumbled 27.6%, snapping a four-day rally fueled by interest from retail traders.</p>\n<p>ViacomCBS Inc jumped 7.1% as the company said it signed up the highest number of new streaming subscribers in the second quarter, and struck a multi-year deal with Comcast Corp's&nbsp;Sky to launch the Paramount+ streaming service in Europe.</p>\n<p>The Dow Jones Industrial Average rose 271.58 points, or 0.78%, to 35,064.25, the S&amp;P 500 gained 26.44 points, or 0.60%, to 4,429.1 and the Nasdaq Composite added 114.58 points, or 0.78%, to 14,895.12.</p>\n<p>Concerns about the pace of economic growth and higher inflation have pressured the S&amp;P 500 index, but stellar corporate earnings so far have put it on track to end the week higher.</p>\n<p>Fed Vice Chair Richard Clarida, a major architect of the central bank's new policy strategy, said on Wednesday he felt the conditions for raising interest rates could be met by the end of 2022.</p>\n<p>Volume on U.S. exchanges was 8.86 billion shares, compared with the 9.63 billion average for the full session over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.26-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 111 new highs and 103 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SH":"标普500反向ETF","IVV":"标普500指数ETF","SPXU":"三倍做空标普500ETF",".IXIC":"NASDAQ Composite","CMCSA":"康卡斯特","SDS":"两倍做空标普500ETF","UPRO":"三倍做多标普500ETF","HOOD":"Robinhood","OEX":"标普100","CI":"信诺保险","SPY":"标普500ETF","SSO":"两倍做多标普500ETF",".SPX":"S&P 500 Index","OEF":"标普100指数ETF-iShares",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157456017","content_text":"* Nasdaq, S&P 500 close at record highs\n* Layoff at lowest in over 21 years\n* Healthcare and materials sectoral losers on S&P 500\nAug 5 (Reuters) - The Nasdaq and S&P 500 closed at record levels on Thursday after a spate of strong corporate earnings and a further decline in U.S. unemployment claims last week, as investors weighed concerns of the surge of the Delta variant ahead of Friday's job's report.\nInitial claims for state unemployment benefits fell by 14,000 to 385,000 in the week ended July 31, while layoffs dropped to their lowest level in more than 21 years last month as companies held on to their workers amid a labor shortage, the Labor Department's report showed.\n\"The directional change has continued to be improving in the last few weeks and now it's a new low since beginning the pandemic,\" said Keith Buchanan, portfolio manager at Globalt Investments in Atlanta, Georgia. \"I think that's what (is) kind of leading to some optimism today and earnings to this point have been positive.\"\nNine of the 11 major S&P 500 sector indexes rose, with healthcare stocks in the red as Cigna Corp slipped 10.9% after predicting a bigger hit to full-year earnings from the pandemic.\nFocus will now shift to the jobs report for July on Friday. Analysts say a disappointing number might raise questions about an economic recovery, but it could also lead the Federal Reserve to remain accommodative.\nMeanwhile, Robinhood Markets Inc tumbled 27.6%, snapping a four-day rally fueled by interest from retail traders.\nViacomCBS Inc jumped 7.1% as the company said it signed up the highest number of new streaming subscribers in the second quarter, and struck a multi-year deal with Comcast Corp's Sky to launch the Paramount+ streaming service in Europe.\nThe Dow Jones Industrial Average rose 271.58 points, or 0.78%, to 35,064.25, the S&P 500 gained 26.44 points, or 0.60%, to 4,429.1 and the Nasdaq Composite added 114.58 points, or 0.78%, to 14,895.12.\nConcerns about the pace of economic growth and higher inflation have pressured the S&P 500 index, but stellar corporate earnings so far have put it on track to end the week higher.\nFed Vice Chair Richard Clarida, a major architect of the central bank's new policy strategy, said on Wednesday he felt the conditions for raising interest rates could be met by the end of 2022.\nVolume on U.S. exchanges was 8.86 billion shares, compared with the 9.63 billion average for the full session over the last 20 trading days.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.06-to-1 ratio; on Nasdaq, a 2.26-to-1 ratio favored advancers.\nThe S&P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 111 new highs and 103 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":25,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802536110,"gmtCreate":1627786882430,"gmtModify":1633756392693,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"🤔🤔🤔","listText":"🤔🤔🤔","text":"🤔🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/802536110","repostId":"2155001152","repostType":4,"repost":{"id":"2155001152","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627675228,"share":"https://www.laohu8.com/m/news/2155001152?lang=&edition=full","pubTime":"2021-07-31 04:00","market":"us","language":"en","title":"Wall Street declines with Amazon; S&P 500 posts gains for month","url":"https://stock-news.laohu8.com/highlight/detail?id=2155001152","media":"Reuters","summary":"U.S. consumer spending rises in June, inflation increases . NEW YORK, July 30  - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&P 500 still posted a sixth straight month of gains.Amazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.Shares of oth","content":"<ul>\n <li>Pinterest sinks on stalled U.S. user growth</li>\n <li>U.S. consumer spending rises in June, inflation increases (Updates to close)</li>\n</ul>\n<p>NEW YORK, July 30 (Reuters) - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&amp;P 500 still posted a sixth straight month of gains.</p>\n<p>Amazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.</p>\n<p>Shares of other internet and tech giants that did well during the lockdowns of last year, including Google parent Alphabet Inc and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc, were mostly lower.</p>\n<p>\"Overall earnings have been good. But Amazon ... and some of last year's winners are taking some of the air out of the market today,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"This market has been driven by big tech and when tech does well, the market seems to go right along with it, and when it doesn't,\" it falls.</p>\n<p>Data on Friday showed U.S. consumer spending rose more than expected in June, although annual inflation accelerated further above the Federal Reserve's 2% target.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 146.36 points, or 0.42%, to 34,938.17, the S&amp;P 500 lost 23.58 points, or 0.53%, to 4,395.57 and the Nasdaq Composite dropped 101.51 points, or 0.69%, to 14,676.76.</p>\n<p>Strong earnings and the continued rebound in the U.S. economy have helped to support stocks this month, but the rapid spread of the Delta variant of the coronavirus and rising inflation have been concerns.</p>\n<p>\"There are still some distant jitters, whispers about the Delta variant, about cases rising, and I think some underlying worries about a slowdown of the reopenings and possible reversal,\" Dollarhide said.</p>\n<p>Also on the earnings front, Pampers maker Procter &amp; Gamble Co rose as it forecast higher core earnings for this year, and U.S.-listed shares of Canada's <a href=\"https://laohu8.com/S/QSR\">Restaurant Brands International Inc</a> jumped after the Burger King owner beat estimates for quarterly profit.</p>\n<p>Pinterest Inc, however, plunged after saying U.S. user growth was decelerating as people who used the platform for crafts and DIY projects during the height of the pandemic were stepping out more.</p>\n<p>Caterpillar Inc shares also fell, even though the company posted a rise in second-quarter adjusted profit on the back of a recovery in global economic activity.</p>\n<p>Results on the quarter overall have been much stronger than expected, with about 89% of the reports beating analysts' estimates on earnings, according to IBES data from Refinitiv. Earnings are now expected to have climbed 89.8% in the second quarter versus forecasts of 65.4% at the start of July. (Reporting by Caroline Valetkevitch in New York Additional reporting by Sagarika Jaisinghani in Bengaluru Editing by Arun Koyyur and Matthew Lewis)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street declines with Amazon; S&P 500 posts gains for month</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street declines with Amazon; S&P 500 posts gains for month\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-31 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Pinterest sinks on stalled U.S. user growth</li>\n <li>U.S. consumer spending rises in June, inflation increases (Updates to close)</li>\n</ul>\n<p>NEW YORK, July 30 (Reuters) - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&amp;P 500 still posted a sixth straight month of gains.</p>\n<p>Amazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.</p>\n<p>Shares of other internet and tech giants that did well during the lockdowns of last year, including Google parent Alphabet Inc and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc, were mostly lower.</p>\n<p>\"Overall earnings have been good. But Amazon ... and some of last year's winners are taking some of the air out of the market today,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"This market has been driven by big tech and when tech does well, the market seems to go right along with it, and when it doesn't,\" it falls.</p>\n<p>Data on Friday showed U.S. consumer spending rose more than expected in June, although annual inflation accelerated further above the Federal Reserve's 2% target.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 146.36 points, or 0.42%, to 34,938.17, the S&amp;P 500 lost 23.58 points, or 0.53%, to 4,395.57 and the Nasdaq Composite dropped 101.51 points, or 0.69%, to 14,676.76.</p>\n<p>Strong earnings and the continued rebound in the U.S. economy have helped to support stocks this month, but the rapid spread of the Delta variant of the coronavirus and rising inflation have been concerns.</p>\n<p>\"There are still some distant jitters, whispers about the Delta variant, about cases rising, and I think some underlying worries about a slowdown of the reopenings and possible reversal,\" Dollarhide said.</p>\n<p>Also on the earnings front, Pampers maker Procter &amp; Gamble Co rose as it forecast higher core earnings for this year, and U.S.-listed shares of Canada's <a href=\"https://laohu8.com/S/QSR\">Restaurant Brands International Inc</a> jumped after the Burger King owner beat estimates for quarterly profit.</p>\n<p>Pinterest Inc, however, plunged after saying U.S. user growth was decelerating as people who used the platform for crafts and DIY projects during the height of the pandemic were stepping out more.</p>\n<p>Caterpillar Inc shares also fell, even though the company posted a rise in second-quarter adjusted profit on the back of a recovery in global economic activity.</p>\n<p>Results on the quarter overall have been much stronger than expected, with about 89% of the reports beating analysts' estimates on earnings, according to IBES data from Refinitiv. Earnings are now expected to have climbed 89.8% in the second quarter versus forecasts of 65.4% at the start of July. (Reporting by Caroline Valetkevitch in New York Additional reporting by Sagarika Jaisinghani in Bengaluru Editing by Arun Koyyur and Matthew Lewis)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SSO":"两倍做多标普500ETF","SPY":"标普500ETF","AMZN":"亚马逊","CAT":"卡特彼勒","OEF":"标普100指数ETF-iShares",".SPX":"S&P 500 Index","COMP":"Compass, Inc.","OEX":"标普100","SPXU":"三倍做空标普500ETF","UPRO":"三倍做多标普500ETF","IVV":"标普500指数ETF","SH":"标普500反向ETF","SDS":"两倍做空标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155001152","content_text":"Pinterest sinks on stalled U.S. user growth\nU.S. consumer spending rises in June, inflation increases (Updates to close)\n\nNEW YORK, July 30 (Reuters) - U.S. stocks fell on Friday with Amazon.com shares declining after the company forecast lower sales growth, but the S&P 500 still posted a sixth straight month of gains.\nAmazon.com Inc shares sank after it reported late on Thursday revenue for the second quarter that was shy of analysts' average estimate and said sales growth would ease in the next few quarters as customers ventured more outside the home.\nShares of other internet and tech giants that did well during the lockdowns of last year, including Google parent Alphabet Inc and Facebook Inc, were mostly lower.\n\"Overall earnings have been good. But Amazon ... and some of last year's winners are taking some of the air out of the market today,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"This market has been driven by big tech and when tech does well, the market seems to go right along with it, and when it doesn't,\" it falls.\nData on Friday showed U.S. consumer spending rose more than expected in June, although annual inflation accelerated further above the Federal Reserve's 2% target.\nUnofficially, the Dow Jones Industrial Average fell 146.36 points, or 0.42%, to 34,938.17, the S&P 500 lost 23.58 points, or 0.53%, to 4,395.57 and the Nasdaq Composite dropped 101.51 points, or 0.69%, to 14,676.76.\nStrong earnings and the continued rebound in the U.S. economy have helped to support stocks this month, but the rapid spread of the Delta variant of the coronavirus and rising inflation have been concerns.\n\"There are still some distant jitters, whispers about the Delta variant, about cases rising, and I think some underlying worries about a slowdown of the reopenings and possible reversal,\" Dollarhide said.\nAlso on the earnings front, Pampers maker Procter & Gamble Co rose as it forecast higher core earnings for this year, and U.S.-listed shares of Canada's Restaurant Brands International Inc jumped after the Burger King owner beat estimates for quarterly profit.\nPinterest Inc, however, plunged after saying U.S. user growth was decelerating as people who used the platform for crafts and DIY projects during the height of the pandemic were stepping out more.\nCaterpillar Inc shares also fell, even though the company posted a rise in second-quarter adjusted profit on the back of a recovery in global economic activity.\nResults on the quarter overall have been much stronger than expected, with about 89% of the reports beating analysts' estimates on earnings, according to IBES data from Refinitiv. Earnings are now expected to have climbed 89.8% in the second quarter versus forecasts of 65.4% at the start of July. (Reporting by Caroline Valetkevitch in New York Additional reporting by Sagarika Jaisinghani in Bengaluru Editing by Arun Koyyur and Matthew Lewis)","news_type":1},"isVote":1,"tweetType":1,"viewCount":130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816919146,"gmtCreate":1630459777685,"gmtModify":1633677907233,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/816919146","repostId":"2164869989","repostType":4,"isVote":1,"tweetType":1,"viewCount":31,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":699234886,"gmtCreate":1639806218059,"gmtModify":1639806218223,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699234886","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","kind":"news","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p>\n<p>All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p>\n<p>Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p>\n<p>The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p>\n<p>All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p>\n<p>Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p>\n<p>Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p>\n<p>\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p>\n<p>Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p>\n<p>In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p>\n<p>The Nasdaq Composite dropped 0.07% to 15,169.68.</p>\n<p>On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p>\n<p>With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p>\n<p>For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p>\n<p>In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p>\n<p>FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600388344,"gmtCreate":1638067713162,"gmtModify":1638067713283,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600388344","repostId":"2186340224","repostType":4,"repost":{"id":"2186340224","kind":"highlight","pubTimestamp":1638059445,"share":"https://www.laohu8.com/m/news/2186340224?lang=&edition=full","pubTime":"2021-11-28 08:30","market":"us","language":"en","title":"Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2186340224","media":"Motley Fool","summary":"Both of these businesses could be in much better shape a year from now.","content":"<p>Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. But if you're investing for the long haul, you know that short-term trends could subside, and this year's sell-off stock could be next year's top performer.</p>\n<p>That's exactly what I think of with&nbsp;<a href=\"https://laohu8.com/S/AZN\"><b>AstraZeneca&nbsp;</b></a> and&nbsp;<a href=\"https://laohu8.com/S/BYND\"><b>Beyond Meat&nbsp;</b></a>. Both of these stocks have been falling recently, but heading into next year, things could look a lot better. If you can afford to invest $5,000 into these stocks, here's why you should consider doing so.</p>\n<h4><b>1. AstraZeneca</b></h4>\n<p>Shares of COVID-19 vaccine-maker AstraZeneca are down 5% over the past three months, while the <b>S&amp;P 500</b> has soared by more than 5%. The company released its third-quarter results on Nov. 12, which disappointed investors as it fell short of earnings expectations. The stock sank more than 6% on the day.</p>\n<p>But next year, things could look much different. Up until now, AstraZeneca hasn't been trying to make a profit from its COVID-19 vaccine. But now that the pandemic is turning into more of an endemic, the company is going to focus on turning a profit on the vaccine on any new orders.</p>\n<p>That means an increase in price. The company has been selling its vaccine for just a few dollars per dose, well below what other COVID-19 vaccine makers are charging countries.</p>\n<p>For the period ending Sept. 30, the company's COVID-19 vaccine generated over $1 billion in revenue. Meanwhile, rival vaccine-maker <b>Moderna</b> reported $4.8 billion in product sales for the same period, and <b>Pfizer</b>'s COVID-19 vaccine generated $13 billion in revenue, also during the same interval.</p>\n<p>While it's unclear just how much higher AstraZeneca's COVID-19-related revenue may climb on an increase in the vaccine's price, its top line is likely to get a boost next year nonetheless. Plus, it completed the acquisition of healthcare-company Alexion Pharmaceuticals in July, which has already started contributing to AstraZeneca's financials this past quarter to the tune of $1.3 billion in new revenue. Alexion's focus on rare diseases expands AstraZeneca's product mix and can set it up for some great gains over the long term.</p>\n<p>Although AstraZeneca incurred a net loss of $1.7 billion this past quarter, that's largely due to the acquisition of Alexion, as its operations are typically profitable. (In each of the previous four quarters, AstraZeneca has reported a profit margin of at least 6%.)</p>\n<p>As it integrates Alexion into its business and eliminates inefficiencies and redundancies, the company's financials will improve. That, combined with the additional revenue from the new business plus an increase in COVID-19 sales, could set the stock up for a terrific performance in 2022.</p>\n<h4><b>2. Beyond Meat</b></h4>\n<p>Beyond Meat's stock has been falling fast as it's down 36% in just three months. What was looking like it might be a promising year for the company amid reopenings has stalled due to the delta variant causing a spike in COVID-19 cases.</p>\n<p>The company had a bad earnings report and the stock has become a better buy in November. Although sales of $106.4 million for the period ending Oct. 2 rose 13% year over year, the company disappointed investors with a net loss of $54.8 million that was more than double the $19.3 million loss it reported in the same period in 2020. Beyond Meat doesn't project a picture of getting much better in the final quarter of the year, as it expects net revenue to fall within a range of just $85 million to $110 million.</p>\n<p>There's no shortage of bearishness surrounding Beyond Meat right now. But heading into next year, a lot can change. What's important is that the company has some great growth opportunities in place.</p>\n<p>Beyond's sales were up 13% this past quarter, but that was driven primarily by growth in the international markets, where revenue more than doubled to $38.9 million. In the U.S. market, sales of $67.5 million declined by 14%.</p>\n<p>However, if supply-chain issues resolve next year and COVID-19 case numbers come down as people receive booster shots, there's reason to believe that the U.S. numbers could strengthen with a return to normalcy in the economy. And fast-food restaurant <b>McDonald's</b> recently launched its McPlant burger (which features a Beyond Meat patty) in multiple U.S. cities. If successful, that could also lead to some improved financials for Beyond in 2022.</p>\n<p>Although the growth stock is beaten up today, a year from now, today's price could look like a bargain.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $5,000? These 2 Stocks Could Be Bargain Buys in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 08:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/27/these-2-stocks-could-be-bargain-buys-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. But if you're investing for the long haul, you know that short-term trends could subside, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/27/these-2-stocks-could-be-bargain-buys-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BYND":"Beyond Meat, Inc.","AZN":"阿斯利康"},"source_url":"https://www.fool.com/investing/2021/11/27/these-2-stocks-could-be-bargain-buys-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186340224","content_text":"Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. But if you're investing for the long haul, you know that short-term trends could subside, and this year's sell-off stock could be next year's top performer.\nThat's exactly what I think of with AstraZeneca  and Beyond Meat . Both of these stocks have been falling recently, but heading into next year, things could look a lot better. If you can afford to invest $5,000 into these stocks, here's why you should consider doing so.\n1. AstraZeneca\nShares of COVID-19 vaccine-maker AstraZeneca are down 5% over the past three months, while the S&P 500 has soared by more than 5%. The company released its third-quarter results on Nov. 12, which disappointed investors as it fell short of earnings expectations. The stock sank more than 6% on the day.\nBut next year, things could look much different. Up until now, AstraZeneca hasn't been trying to make a profit from its COVID-19 vaccine. But now that the pandemic is turning into more of an endemic, the company is going to focus on turning a profit on the vaccine on any new orders.\nThat means an increase in price. The company has been selling its vaccine for just a few dollars per dose, well below what other COVID-19 vaccine makers are charging countries.\nFor the period ending Sept. 30, the company's COVID-19 vaccine generated over $1 billion in revenue. Meanwhile, rival vaccine-maker Moderna reported $4.8 billion in product sales for the same period, and Pfizer's COVID-19 vaccine generated $13 billion in revenue, also during the same interval.\nWhile it's unclear just how much higher AstraZeneca's COVID-19-related revenue may climb on an increase in the vaccine's price, its top line is likely to get a boost next year nonetheless. Plus, it completed the acquisition of healthcare-company Alexion Pharmaceuticals in July, which has already started contributing to AstraZeneca's financials this past quarter to the tune of $1.3 billion in new revenue. Alexion's focus on rare diseases expands AstraZeneca's product mix and can set it up for some great gains over the long term.\nAlthough AstraZeneca incurred a net loss of $1.7 billion this past quarter, that's largely due to the acquisition of Alexion, as its operations are typically profitable. (In each of the previous four quarters, AstraZeneca has reported a profit margin of at least 6%.)\nAs it integrates Alexion into its business and eliminates inefficiencies and redundancies, the company's financials will improve. That, combined with the additional revenue from the new business plus an increase in COVID-19 sales, could set the stock up for a terrific performance in 2022.\n2. Beyond Meat\nBeyond Meat's stock has been falling fast as it's down 36% in just three months. What was looking like it might be a promising year for the company amid reopenings has stalled due to the delta variant causing a spike in COVID-19 cases.\nThe company had a bad earnings report and the stock has become a better buy in November. Although sales of $106.4 million for the period ending Oct. 2 rose 13% year over year, the company disappointed investors with a net loss of $54.8 million that was more than double the $19.3 million loss it reported in the same period in 2020. Beyond Meat doesn't project a picture of getting much better in the final quarter of the year, as it expects net revenue to fall within a range of just $85 million to $110 million.\nThere's no shortage of bearishness surrounding Beyond Meat right now. But heading into next year, a lot can change. What's important is that the company has some great growth opportunities in place.\nBeyond's sales were up 13% this past quarter, but that was driven primarily by growth in the international markets, where revenue more than doubled to $38.9 million. In the U.S. market, sales of $67.5 million declined by 14%.\nHowever, if supply-chain issues resolve next year and COVID-19 case numbers come down as people receive booster shots, there's reason to believe that the U.S. numbers could strengthen with a return to normalcy in the economy. And fast-food restaurant McDonald's recently launched its McPlant burger (which features a Beyond Meat patty) in multiple U.S. cities. If successful, that could also lead to some improved financials for Beyond in 2022.\nAlthough the growth stock is beaten up today, a year from now, today's price could look like a bargain.","news_type":1},"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871183374,"gmtCreate":1637036487978,"gmtModify":1637036487978,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/871183374","repostId":"2183100852","repostType":4,"repost":{"id":"2183100852","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637032751,"share":"https://www.laohu8.com/m/news/2183100852?lang=&edition=full","pubTime":"2021-11-16 11:19","market":"us","language":"en","title":"Grab's ride-hailing services disrupted in Southeast Asian countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2183100852","media":"Reuters","summary":"(Reuters) - Southeast Asia's Grab on Tuesday said it was experiencing a disruption to its services, ","content":"<p> (Reuters) - Southeast Asia's Grab on Tuesday said it was experiencing a disruption to its services, with customers and drivers in Singapore, Indonesia and Malaysia complaining that they were having trouble using the app's ride-hailing functions.</p>\n<p>\"Some of our services are not accessible at the moment,\" Grab posted on its Facebook page.</p>\n<p>\"We are looking into this and we will update when the app is back up and running.\"</p>\n<p>Grab operates Southeast Asia's most popular \"super app\", which provide ride-hailing, food and grocery delivery and payments in over 400 locations in eight countries.</p>\n<p>\"We are experiencing some technical difficulties with the app and our engineers are working to recover the issue,\" Grab said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab's ride-hailing services disrupted in Southeast Asian countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab's ride-hailing services disrupted in Southeast Asian countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-16 11:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p> (Reuters) - Southeast Asia's Grab on Tuesday said it was experiencing a disruption to its services, with customers and drivers in Singapore, Indonesia and Malaysia complaining that they were having trouble using the app's ride-hailing functions.</p>\n<p>\"Some of our services are not accessible at the moment,\" Grab posted on its Facebook page.</p>\n<p>\"We are looking into this and we will update when the app is back up and running.\"</p>\n<p>Grab operates Southeast Asia's most popular \"super app\", which provide ride-hailing, food and grocery delivery and payments in over 400 locations in eight countries.</p>\n<p>\"We are experiencing some technical difficulties with the app and our engineers are working to recover the issue,\" Grab said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2183100852","content_text":"(Reuters) - Southeast Asia's Grab on Tuesday said it was experiencing a disruption to its services, with customers and drivers in Singapore, Indonesia and Malaysia complaining that they were having trouble using the app's ride-hailing functions.\n\"Some of our services are not accessible at the moment,\" Grab posted on its Facebook page.\n\"We are looking into this and we will update when the app is back up and running.\"\nGrab operates Southeast Asia's most popular \"super app\", which provide ride-hailing, food and grocery delivery and payments in over 400 locations in eight countries.\n\"We are experiencing some technical difficulties with the app and our engineers are working to recover the issue,\" Grab said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870135873,"gmtCreate":1636592483482,"gmtModify":1636592483482,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870135873","repostId":"1125156072","repostType":4,"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846735995,"gmtCreate":1636112963403,"gmtModify":1636112963569,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/846735995","repostId":"1166866310","repostType":4,"repost":{"id":"1166866310","kind":"news","pubTimestamp":1636112660,"share":"https://www.laohu8.com/m/news/1166866310?lang=&edition=full","pubTime":"2021-11-05 19:44","market":"us","language":"en","title":"Pfizer Develops Covid Pill That Cuts Hospitalizations and Deaths by 89%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166866310","media":"Bloomberg","summary":"Drug reduced Covid hospitalizations by 89% in clinical trial\nPfizer shares surge 11%; Merck pill awa","content":"<ul>\n <li>Drug reduced Covid hospitalizations by 89% in clinical trial</li>\n <li>Pfizer shares surge 11%; Merck pill awaiting U.S. approval</li>\n</ul>\n<p>Pfizer Inc.&nbsp;said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%, a result that has the potential to upend how the disease caused by the coronavirus is treated and alter the course of the pandemic. The shares surged 11%.</p>\n<p>The drugmaker said in a statement on Friday that it was no longer taking new patients in a clinical trial of the treatment “due to the overwhelming efficacy” and planned to submit the findings to U.S. regulatory authorities for emergency authorization as soon as possible.</p>\n<p>The results mean there are now two promising candidates for treating Covid-19 patients early in the course of the disease. Last month,Merck &amp; Co.&nbsp;and partner Ridgeback Biotherapeutics LP submitted their experimental pill to regulators after a study showed it slashed the risk of getting seriously ill or dying&nbsp;by half&nbsp;in patients with mild-to-moderate Covid-19.</p>\n<p>Pfizer gained 11% in premarket U.S. trading, while Merck fell 6.6%. Some vaccine makers lost ground, with&nbsp;Moderna Inc&nbsp;.down 4.5% and Pfizer partner&nbsp;BioNTech&nbsp;SE slipping 4% in German trading.</p>\n<p>A pill that could be taken at home at the first sign of symptoms is a crucial tool for taming the Covid-19 crisis globally, so long as it’s widely available. A Pfizer spokesperson said submissions to other regulatory agencies will occur shortly after the U.S. filing.</p>\n<p>In Pfizer’s trial of 1,219 unvaccinated adults, five days of treatment with its drug dramatically reduced the rate of hospitalization when it was started within either three days or five days of symptom onset, the company said. The drug, Paxlovid, binds to an enzyme called a protease to stop the virus from replicating itself. Some drugs for HIV work in a similar way.</p>\n<p>Overall, just 0.8% of people who started treatment within three days of getting sick ended up in the hospital and no one died, while 7% of people who got a placebo in that window were later hospitalized or died. Similar results were found when the drug was started within five days of symptom onset. The result, which hasn’t been published in a medical journal, was highly statistically significant, Pfizer said.</p>\n<p><b>Acute Need</b></p>\n<p>Current treatment options for Covid aren’t ideal. Monoclonal antibodies from companies like&nbsp;Regeneron Pharmaceuticals Inc.&nbsp;and&nbsp;Eli Lilly &amp; Co.&nbsp;reduce hospitalizations, but the infusions are hard to manufacture and must be given in a medical office, adding to the strain on health systems.</p>\n<p>Other medications like&nbsp;Gilead Sciences Inc.’s remdesivir are used to treat much sicker people who are already in the hospital. Low-cost steroid dexamethasone, while very effective, is usually only given to gravely ill patients.</p>\n<p>The need for a pill is so acute that Merck has&nbsp;already agreed&nbsp;to allow generic drugmakers to apply for licenses to make its treatment for more than 100 low- and middle-income nations, before it has even been cleared in the U.S. The U.K.’s drug regulators became the first in the world&nbsp;to greenlight&nbsp;Merck’s drug Thursday after a swift review.</p>\n<p>Now Pfizer’s pill, which works by a different mechanism, appears to have produced even better results in high-risk patients. The trial was stopped early by independent monitors because the effect was so impressive.</p>\n<p>“We are really over the moon that we did see such high efficacy in this study. It has tremendous implications for patients globally,” said Annaliesa Anderson, chief scientific officer for Pfizer’s hospitals business unit, which includes its antiviral work.</p>\n<p>In addition to the current trial in high-risk patients, Pfizer is also testing the drug in standard-risk patients, a study that included some vaccinated people who had breakthrough infections.</p>\n<p>In a third large trial, Pfizer is exploring if the drug could be used as a prophylactic medicine for people who live with someone who has come down with Covid-19, meaning a person would take the drug to avoid contracting the virus.</p>\n<p><b>Old Molecule</b></p>\n<p>The pill was internally developed by Pfizer researchers in the U.S. and U.K. During the early pandemic shutdowns, the scientists agreed to come back to their labs in an urgent effort to develop anti-Covid pills, Anderson said. Company researchers “worked around the clock to design this molecule” in a highly-compressed timeframe, she said.</p>\n<p>They dusted off an old experimental antiviral drug that Pfizer had developed after the original SARS epidemic, a coronavirus cousin to Covid-19 that killed about 800 people starting in late 2002. The old drug needed to be administered intravenously. But by July of last year, the Pfizer researchers tweaked the original molecule and came up with a new compound that turned out to be highly potent against Covid-19 and other coronaviruses in the test tube -- and could be used as a pill.</p>\n<p>The Pfizer drug works to block a crucial enzyme that the Covid-19 virus needs to replicate. It is taken twice a day for five days and used in combination with a second medicine called ritonavir that helps the Pfizer compound stay in the bloodstream longer.</p>\n<p>Pfizer said it planned to offer the antiviral therapy through a tiered pricing approach during the pandemic. High and upper-middle income countries will pay more than lower income countries, it said. The drugmaker didn’t say exactly how much it would charge.</p>\n<p>A Pfizer spokesperson said the company currently expects to produce more than 180,000 packs of the drug by the end of this year, and anticipates making at least 50 million packs by the end of 2022, with 21 million produced in the first half of the year.</p>\n<p></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Develops Covid Pill That Cuts Hospitalizations and Deaths by 89%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Develops Covid Pill That Cuts Hospitalizations and Deaths by 89%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 19:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-05/pfizer-to-seek-u-s-nod-for-covid-pill-after-strong-results?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Drug reduced Covid hospitalizations by 89% in clinical trial\nPfizer shares surge 11%; Merck pill awaiting U.S. approval\n\nPfizer Inc. said its Covid-19 pill reduced hospitalizations and deaths in high-...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-05/pfizer-to-seek-u-s-nod-for-covid-pill-after-strong-results?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.bloomberg.com/news/articles/2021-11-05/pfizer-to-seek-u-s-nod-for-covid-pill-after-strong-results?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166866310","content_text":"Drug reduced Covid hospitalizations by 89% in clinical trial\nPfizer shares surge 11%; Merck pill awaiting U.S. approval\n\nPfizer Inc. said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%, a result that has the potential to upend how the disease caused by the coronavirus is treated and alter the course of the pandemic. The shares surged 11%.\nThe drugmaker said in a statement on Friday that it was no longer taking new patients in a clinical trial of the treatment “due to the overwhelming efficacy” and planned to submit the findings to U.S. regulatory authorities for emergency authorization as soon as possible.\nThe results mean there are now two promising candidates for treating Covid-19 patients early in the course of the disease. Last month,Merck & Co. and partner Ridgeback Biotherapeutics LP submitted their experimental pill to regulators after a study showed it slashed the risk of getting seriously ill or dying by half in patients with mild-to-moderate Covid-19.\nPfizer gained 11% in premarket U.S. trading, while Merck fell 6.6%. Some vaccine makers lost ground, with Moderna Inc .down 4.5% and Pfizer partner BioNTech SE slipping 4% in German trading.\nA pill that could be taken at home at the first sign of symptoms is a crucial tool for taming the Covid-19 crisis globally, so long as it’s widely available. A Pfizer spokesperson said submissions to other regulatory agencies will occur shortly after the U.S. filing.\nIn Pfizer’s trial of 1,219 unvaccinated adults, five days of treatment with its drug dramatically reduced the rate of hospitalization when it was started within either three days or five days of symptom onset, the company said. The drug, Paxlovid, binds to an enzyme called a protease to stop the virus from replicating itself. Some drugs for HIV work in a similar way.\nOverall, just 0.8% of people who started treatment within three days of getting sick ended up in the hospital and no one died, while 7% of people who got a placebo in that window were later hospitalized or died. Similar results were found when the drug was started within five days of symptom onset. The result, which hasn’t been published in a medical journal, was highly statistically significant, Pfizer said.\nAcute Need\nCurrent treatment options for Covid aren’t ideal. Monoclonal antibodies from companies like Regeneron Pharmaceuticals Inc. and Eli Lilly & Co. reduce hospitalizations, but the infusions are hard to manufacture and must be given in a medical office, adding to the strain on health systems.\nOther medications like Gilead Sciences Inc.’s remdesivir are used to treat much sicker people who are already in the hospital. Low-cost steroid dexamethasone, while very effective, is usually only given to gravely ill patients.\nThe need for a pill is so acute that Merck has already agreed to allow generic drugmakers to apply for licenses to make its treatment for more than 100 low- and middle-income nations, before it has even been cleared in the U.S. The U.K.’s drug regulators became the first in the world to greenlight Merck’s drug Thursday after a swift review.\nNow Pfizer’s pill, which works by a different mechanism, appears to have produced even better results in high-risk patients. The trial was stopped early by independent monitors because the effect was so impressive.\n“We are really over the moon that we did see such high efficacy in this study. It has tremendous implications for patients globally,” said Annaliesa Anderson, chief scientific officer for Pfizer’s hospitals business unit, which includes its antiviral work.\nIn addition to the current trial in high-risk patients, Pfizer is also testing the drug in standard-risk patients, a study that included some vaccinated people who had breakthrough infections.\nIn a third large trial, Pfizer is exploring if the drug could be used as a prophylactic medicine for people who live with someone who has come down with Covid-19, meaning a person would take the drug to avoid contracting the virus.\nOld Molecule\nThe pill was internally developed by Pfizer researchers in the U.S. and U.K. During the early pandemic shutdowns, the scientists agreed to come back to their labs in an urgent effort to develop anti-Covid pills, Anderson said. Company researchers “worked around the clock to design this molecule” in a highly-compressed timeframe, she said.\nThey dusted off an old experimental antiviral drug that Pfizer had developed after the original SARS epidemic, a coronavirus cousin to Covid-19 that killed about 800 people starting in late 2002. The old drug needed to be administered intravenously. But by July of last year, the Pfizer researchers tweaked the original molecule and came up with a new compound that turned out to be highly potent against Covid-19 and other coronaviruses in the test tube -- and could be used as a pill.\nThe Pfizer drug works to block a crucial enzyme that the Covid-19 virus needs to replicate. It is taken twice a day for five days and used in combination with a second medicine called ritonavir that helps the Pfizer compound stay in the bloodstream longer.\nPfizer said it planned to offer the antiviral therapy through a tiered pricing approach during the pandemic. High and upper-middle income countries will pay more than lower income countries, it said. The drugmaker didn’t say exactly how much it would charge.\nA Pfizer spokesperson said the company currently expects to produce more than 180,000 packs of the drug by the end of this year, and anticipates making at least 50 million packs by the end of 2022, with 21 million produced in the first half of the year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848456162,"gmtCreate":1636022711112,"gmtModify":1636022711227,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/848456162","repostId":"1127498048","repostType":4,"repost":{"id":"1127498048","kind":"news","pubTimestamp":1636021104,"share":"https://www.laohu8.com/m/news/1127498048?lang=&edition=full","pubTime":"2021-11-04 18:18","market":"us","language":"en","title":"Arhaus Prices IPO At $13/Share, Below Expected Range","url":"https://stock-news.laohu8.com/highlight/detail?id=1127498048","media":"Benzinga","summary":"Home furnishings retailer Arhaus Inc NASDAQARHShas priced its initial public offering (IPO) of 12.9 ","content":"<ul>\n <li>Home furnishings retailer<b>&nbsp;Arhaus Inc</b>&nbsp;NASDAQARHShas&nbsp;priced its initial public offering&nbsp;(IPO) of 12.9 million shares at $13.00 per share.</li>\n <li>The company&nbsp;had expected&nbsp;to price the IPO at $14 -$17 earlier.</li>\n <li>The underwriters will have a 30-day option to purchase up to an additional 1.9 million shares from the company.</li>\n <li>The shares are expected to begin trading on the Nasdaq Global Select Market on Thursday, November 4, 2021, under the ticker symbol \"ARHS.\"</li>\n <li>The offering is expected to close on November 8, 2021, subject to customary closing conditions.</li>\n <li>BofA Securities and Jefferies LLC are acting as joint lead book-running managers and as representatives for the proposed offering.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Arhaus Prices IPO At $13/Share, Below Expected Range</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArhaus Prices IPO At $13/Share, Below Expected Range\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 18:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/23882212/arhaus-prices-ipo-at-13share-below-expected-range><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Home furnishings retailer Arhaus Inc NASDAQARHShas priced its initial public offering (IPO) of 12.9 million shares at $13.00 per share.\nThe company had expected to price the IPO at $14 -$17 earlier.\n...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/23882212/arhaus-prices-ipo-at-13share-below-expected-range\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARHS":"Arhaus, Inc."},"source_url":"https://www.benzinga.com/news/21/11/23882212/arhaus-prices-ipo-at-13share-below-expected-range","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127498048","content_text":"Home furnishings retailer Arhaus Inc NASDAQARHShas priced its initial public offering (IPO) of 12.9 million shares at $13.00 per share.\nThe company had expected to price the IPO at $14 -$17 earlier.\nThe underwriters will have a 30-day option to purchase up to an additional 1.9 million shares from the company.\nThe shares are expected to begin trading on the Nasdaq Global Select Market on Thursday, November 4, 2021, under the ticker symbol \"ARHS.\"\nThe offering is expected to close on November 8, 2021, subject to customary closing conditions.\nBofA Securities and Jefferies LLC are acting as joint lead book-running managers and as representatives for the proposed offering.","news_type":1},"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857292253,"gmtCreate":1635526030567,"gmtModify":1635526030567,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/857292253","repostId":"1170077439","repostType":4,"repost":{"id":"1170077439","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635521388,"share":"https://www.laohu8.com/m/news/1170077439?lang=&edition=full","pubTime":"2021-10-29 23:29","market":"us","language":"en","title":"Entrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share","url":"https://stock-news.laohu8.com/highlight/detail?id=1170077439","media":"Tiger Newspress","summary":"Entrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share.Entrada, which is working to develop therapeutics for rare neuromuscular diseases such as Duchenne muscular dystrophy and myotonic dystrophy type 1, said it believes the proceeds, coupled with its existing resources, will be sufficient to fund its operating expenses and capital-spending needs into the second quarter of 2024.","content":"<p>Entrada&nbsp;jumped&nbsp;over&nbsp;30%&nbsp;in&nbsp;morning&nbsp;trading,above&nbsp;its&nbsp;IPO&nbsp;price&nbsp;at&nbsp;20&nbsp;dollars&nbsp;per&nbsp;share.<img src=\"https://static.tigerbbs.com/d7b5af9ada5c6d243935e675a495b080\" tg-width=\"769\" tg-height=\"570\" width=\"100%\" height=\"auto\">Entrada, which is working to develop therapeutics for rare neuromuscular diseases such as Duchenne muscular dystrophy and myotonic dystrophy type 1, said it believes the proceeds, coupled with its existing resources, will be sufficient to fund its operating expenses and capital-spending needs into the second quarter of 2024.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Entrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEntrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-29 23:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Entrada&nbsp;jumped&nbsp;over&nbsp;30%&nbsp;in&nbsp;morning&nbsp;trading,above&nbsp;its&nbsp;IPO&nbsp;price&nbsp;at&nbsp;20&nbsp;dollars&nbsp;per&nbsp;share.<img src=\"https://static.tigerbbs.com/d7b5af9ada5c6d243935e675a495b080\" tg-width=\"769\" tg-height=\"570\" width=\"100%\" height=\"auto\">Entrada, which is working to develop therapeutics for rare neuromuscular diseases such as Duchenne muscular dystrophy and myotonic dystrophy type 1, said it believes the proceeds, coupled with its existing resources, will be sufficient to fund its operating expenses and capital-spending needs into the second quarter of 2024.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRDA":"Entrada Therapeutics, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170077439","content_text":"Entrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share.Entrada, which is working to develop therapeutics for rare neuromuscular diseases such as Duchenne muscular dystrophy and myotonic dystrophy type 1, said it believes the proceeds, coupled with its existing resources, will be sufficient to fund its operating expenses and capital-spending needs into the second quarter of 2024.","news_type":1},"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":854819204,"gmtCreate":1635432200999,"gmtModify":1635432201170,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/854819204","repostId":"2178626213","repostType":4,"isVote":1,"tweetType":1,"viewCount":133,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":852970856,"gmtCreate":1635237341822,"gmtModify":1635237666140,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852970856","repostId":"1129707668","repostType":4,"repost":{"id":"1129707668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635237313,"share":"https://www.laohu8.com/m/news/1129707668?lang=&edition=full","pubTime":"2021-10-26 16:35","market":"us","language":"en","title":"Ocugen soared nearly 30% in premarket trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1129707668","media":"Tiger Newspress","summary":"Ocugen soared nearly 30% in premarket trading because of WHO’s meeting on its partner’s COVID-19 sho","content":"<p>Ocugen soared nearly 30% in premarket trading because of&nbsp;WHO’s&nbsp;meeting on&nbsp;its&nbsp;partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/049beca6a0a0e486b725c38da32051cf\" tg-width=\"768\" tg-height=\"562\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugencooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared nearly 30% in premarket trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared nearly 30% in premarket trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 16:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared nearly 30% in premarket trading because of&nbsp;WHO’s&nbsp;meeting on&nbsp;its&nbsp;partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/049beca6a0a0e486b725c38da32051cf\" tg-width=\"768\" tg-height=\"562\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugencooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129707668","content_text":"Ocugen soared nearly 30% in premarket trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugencooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867165878,"gmtCreate":1633227598989,"gmtModify":1633227599064,"author":{"id":"3561459567222461","authorId":"3561459567222461","name":"Oyh","avatar":"https://static.tigerbbs.com/a893947e58fa2a84ca330f31713a7f7c","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561459567222461","authorIdStr":"3561459567222461"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/867165878","repostId":"2172643049","repostType":4,"repost":{"id":"2172643049","kind":"highlight","pubTimestamp":1633222044,"share":"https://www.laohu8.com/m/news/2172643049?lang=&edition=full","pubTime":"2021-10-03 08:47","market":"us","language":"en","title":"2 Ridiculously Cheap Growth Stocks to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2172643049","media":"Motley Fool","summary":"Though these companies have recorded solid financials of late, investors are overlooking them.","content":"<p>Growth stocks can sometimes trade at inflated valuations because of their attractive long-term potential. So if you get the opportunity to invest in a growth stock that isn't trading at a premium but rather at a discount, you should definitely consider adding it to your portfolio.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> unloved growth stocks that trade at low multiples of future earnings and look incredibly cheap right now are <b>Bristol Myers Squibb</b> (NYSE:BMY) and&nbsp;<b>ViacomCBS </b>(NASDAQ:VIAC).<img src=\"https://static.tigerbbs.com/a1531106e22f32af06a047425395b675\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2>1. Bristol Myers Squibb</h2>\n<p>Healthcare giant Bristol Myers Squibb is a stock that investors could easily be overlooking right now. From afar, its financials look horrible. For the trailing 12 months, the company incurred a net loss of $5 billion. So investors relying on stock screeners to try and find good buys could easily overlook Bristol Myers -- and they have. Year to date, shares of the healthcare stock are down about 2% while the <b>S&amp;P 500</b> has soared 16%.</p>\n<p>But investors who dig a little deeper will find a slightly different story. The huge loss is in fact due to a massive research and development charge of more than $11 billion that the company incurred for its acquisition of MyoKardia, a clinical-stage biopharmaceutical company that develops cardiovascular medicine. That negatively impacted the fourth quarter of last year and is still impacting the trailing 12-month numbers.</p>\n<p>In the past two quarters, however, the company has been firmly in the black. Through the first six months of 2021, Bristol Myers' revenue of $22.8 billion has risen 9% year over year, and its net earnings have flipped from a $846 million loss in 2020 to a $3.1 billion profit.</p>\n<p>Meanwhile, with free cash flow of $11.7 billion over the past four quarters, its dividend also looks rock-solid. The company has paid out $4.2 billion during that time while also making stock repurchases of $4.5 billion. This serves as further proof that accounting income alone can't be relied on to assess the health of a company's operations. Cash flow is arguably a much more important indicator than net income -- and by that metric, Bristol Myers is doing just fine.</p>\n<p>So a closer look at Bristol Myers suggests the company is a much safer buy than its numbers may appear at first glance. A forward price-to-earnings (P/E) ratio can be useful for companies when a bad quarter or two have weighed on their numbers. And by that measure, Bristol Myers only trades at a P/E of 8 — incredibly cheap compared to other healthcare stocks, such as <b>Merck</b> (NYSE:MRK) and <b>Amgen </b>(NASDAQ:AMGN), which both trade at about 13 times their future profits.</p>\n<p>Finally, there's the 3.3% dividend yield, which is more than twice as much as the S&amp;P 500's 1.3%. Whether you're a growth investor or love a good dividend, this is an underrated healthcare stock that should be on your radar.</p>\n<h2>2. ViacomCBS</h2>\n<p>Another stock that's trading at a low valuation is ViacomCBS. At a forward P/E multiple of just 10, it's nowhere near the premium that investors are paying for other companies in the entertainment and streaming business, such as <b>Netflix</b> (NASDAQ:NFLX)&nbsp;and <b>Walt Disney </b>(NYSE:DIS) -- trading at 56 and 70 times their forward profits, respectively.</p>\n<p>Admittedly, ViacomCBS' Paramount+ streaming service isn't as popular, and that could be a reason investors aren't giving the stock as much of a chance. Overall, the company has a total of 42 million global streaming subscribers (including Paramount+ and other smaller services such as Pluto TV). By comparison, Netflix has more than 200 million subscribers while Disney+ now has 116 million.</p>\n<p>But Paramount+ doesn't have to be the top streaming service for ViacomCBS to be an attractive buy. In its latest quarter ended June 30, the company reported that streaming revenue grew 92% to $983 million from the year-ago period and advertising revenue rose 24% to $2.1 billion.</p>\n<p>The lone blemish for the company was its \"licensing and other\" segment, which fell 36% to $1.2 billion -- hurt by the absence of theatrical releases during the pandemic. That kept the company's sales growth relatively modest last quarter, rising 8% to $6.6 billion. However, as the economy continues to recover from the pandemic, those numbers should get stronger.</p>\n<p>Meanwhile, ViacomCBS also offers investors an above-average dividend yield of 2.4%. And with free cash of $2.6 billion over the past 12 months, it is generating more than enough to cover the $601 million in dividends it paid out during that time.</p>\n<p>So, while Paramount+ may be an afterthought for some investors looking to go into top streaming stocks, that in fact could be an opportunity. ViacomCBS shares still fly under the radar -- up just 8% this year. As subscribers continue to increase and revenues improve, it may just be a matter of time before the stock takes off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Ridiculously Cheap Growth Stocks to Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Ridiculously Cheap Growth Stocks to Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-03 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/02/2-ridiculously-cheap-growth-stocks-to-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Growth stocks can sometimes trade at inflated valuations because of their attractive long-term potential. So if you get the opportunity to invest in a growth stock that isn't trading at a premium but ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/02/2-ridiculously-cheap-growth-stocks-to-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","NFLX":"奈飞"},"source_url":"https://www.fool.com/investing/2021/10/02/2-ridiculously-cheap-growth-stocks-to-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172643049","content_text":"Growth stocks can sometimes trade at inflated valuations because of their attractive long-term potential. So if you get the opportunity to invest in a growth stock that isn't trading at a premium but rather at a discount, you should definitely consider adding it to your portfolio.\nTwo unloved growth stocks that trade at low multiples of future earnings and look incredibly cheap right now are Bristol Myers Squibb (NYSE:BMY) and ViacomCBS (NASDAQ:VIAC).\nImage source: Getty Images.\n1. Bristol Myers Squibb\nHealthcare giant Bristol Myers Squibb is a stock that investors could easily be overlooking right now. From afar, its financials look horrible. For the trailing 12 months, the company incurred a net loss of $5 billion. So investors relying on stock screeners to try and find good buys could easily overlook Bristol Myers -- and they have. Year to date, shares of the healthcare stock are down about 2% while the S&P 500 has soared 16%.\nBut investors who dig a little deeper will find a slightly different story. The huge loss is in fact due to a massive research and development charge of more than $11 billion that the company incurred for its acquisition of MyoKardia, a clinical-stage biopharmaceutical company that develops cardiovascular medicine. That negatively impacted the fourth quarter of last year and is still impacting the trailing 12-month numbers.\nIn the past two quarters, however, the company has been firmly in the black. Through the first six months of 2021, Bristol Myers' revenue of $22.8 billion has risen 9% year over year, and its net earnings have flipped from a $846 million loss in 2020 to a $3.1 billion profit.\nMeanwhile, with free cash flow of $11.7 billion over the past four quarters, its dividend also looks rock-solid. The company has paid out $4.2 billion during that time while also making stock repurchases of $4.5 billion. This serves as further proof that accounting income alone can't be relied on to assess the health of a company's operations. Cash flow is arguably a much more important indicator than net income -- and by that metric, Bristol Myers is doing just fine.\nSo a closer look at Bristol Myers suggests the company is a much safer buy than its numbers may appear at first glance. A forward price-to-earnings (P/E) ratio can be useful for companies when a bad quarter or two have weighed on their numbers. And by that measure, Bristol Myers only trades at a P/E of 8 — incredibly cheap compared to other healthcare stocks, such as Merck (NYSE:MRK) and Amgen (NASDAQ:AMGN), which both trade at about 13 times their future profits.\nFinally, there's the 3.3% dividend yield, which is more than twice as much as the S&P 500's 1.3%. Whether you're a growth investor or love a good dividend, this is an underrated healthcare stock that should be on your radar.\n2. ViacomCBS\nAnother stock that's trading at a low valuation is ViacomCBS. At a forward P/E multiple of just 10, it's nowhere near the premium that investors are paying for other companies in the entertainment and streaming business, such as Netflix (NASDAQ:NFLX) and Walt Disney (NYSE:DIS) -- trading at 56 and 70 times their forward profits, respectively.\nAdmittedly, ViacomCBS' Paramount+ streaming service isn't as popular, and that could be a reason investors aren't giving the stock as much of a chance. Overall, the company has a total of 42 million global streaming subscribers (including Paramount+ and other smaller services such as Pluto TV). By comparison, Netflix has more than 200 million subscribers while Disney+ now has 116 million.\nBut Paramount+ doesn't have to be the top streaming service for ViacomCBS to be an attractive buy. In its latest quarter ended June 30, the company reported that streaming revenue grew 92% to $983 million from the year-ago period and advertising revenue rose 24% to $2.1 billion.\nThe lone blemish for the company was its \"licensing and other\" segment, which fell 36% to $1.2 billion -- hurt by the absence of theatrical releases during the pandemic. That kept the company's sales growth relatively modest last quarter, rising 8% to $6.6 billion. However, as the economy continues to recover from the pandemic, those numbers should get stronger.\nMeanwhile, ViacomCBS also offers investors an above-average dividend yield of 2.4%. And with free cash of $2.6 billion over the past 12 months, it is generating more than enough to cover the $601 million in dividends it paid out during that time.\nSo, while Paramount+ may be an afterthought for some investors looking to go into top streaming stocks, that in fact could be an opportunity. ViacomCBS shares still fly under the radar -- up just 8% this year. As subscribers continue to increase and revenues improve, it may just be a matter of time before the stock takes off.","news_type":1},"isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}